UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q



þ		QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
		For the quarterly period ended March 31, ~~2017~~2018



o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 0-15946

Ebix, Inc.

(Exact name of registrant as specified in its charter)




DELAWARE		77-0021975
(State or other jurisdiction of incorporation or		(I.R.S. Employer Identification No.)
organization)

1 EBIX WAY
JOHNS CREEK, GEORGIA		30097
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: 678-281-2020

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer þ	Accelerated filer o	Non-accelerated filer o (Do not check if a smaller reporting company)	Smaller reporting company o	Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ

As of May ~~8, 2017~~7, 2018 the number of shares of common stock outstanding was ~~31,533,557.~~31,467,615.

FORM 10-Q

FOR THE QUARTER ENDED MARCH 31, ~~2017~~2018

INDEX



PART I — FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

Condensed Consolidated Statements of Income for the three months ended March 31, ~~2017~~2018 and ~~2016~~2017 (unaudited)	2

Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, ~~2017~~2018 and ~~2016~~2017 (unaudited)	3

Condensed Consolidated Balance Sheets at March 31, ~~2017~~2018 (unaudited) and December 31, ~~2016~~2017	4

Condensed Consolidated Statement of Stockholders’ Equity for the three months ended March 31, ~~2017~~2018 (unaudited)	6

Condensed Consolidated Statements of Cash Flows for the three months ended March 31, ~~2017~~2018 and ~~2016~~2017 (unaudited)	7

Notes to Condensed Consolidated Financial Statements (unaudited)	89

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	2732

Item 3. Quantitative and Qualitative Disclosures About Market Risk	3743

Item 4. Controls and Procedures	3844

PART II — OTHER INFORMATION

Item 1. Legal Proceedings	3844

Item 1A. Risk Factors	3945

Item 2. Repurchases of Equity Securities	4046

Item 3. Defaults upon Senior Securities	4046

Item 4. Mine Safety Disclosures	4046

Item 5. Other Information	4046

Item 6. Exhibits	4047

EXHIBITS INDEX	48

SIGNATURES	4149

~~EXHIBIT INDEX~~	42

Exhibit 31.1
Exhibit 31.2
Exhibit 32.1
Exhibit 32.2
Exhibit 101

Table of Contents

PART I — FINANCIAL INFORMATION

Item 1: CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Ebix, Inc. and Subsidiaries

Condensed Consolidated Statements of Income

(In thousands, except per share data)

(Unaudited)


	Three Months Ended						Three Months Ended
	March 31,						March 31,
	2017			2016			2018			2017
Operating revenue	$	79,103		$	71,066		$	108,230		$	79,103

Operating expenses:
Cost of services provided	25,187			19,602			39,591			25,187
Product development	8,350			8,065			8,434			8,350
Sales and marketing	4,337			4,333			3,998			4,337
General and administrative, net (see Note 3)	12,684			11,583
General and administrative, net (see Note 1)							19,504			12,684
Amortization and depreciation	2,855			2,720			2,807			2,855
Total operating expenses	53,413			46,303			74,334			53,413

Operating income	25,690			24,763			33,896			25,690
Interest income	774			143			121			774
Interest expense	(2,468		)	(1,274		)	(4,847		)	(2,468		)
Foreign currency exchange gain	3,496			469
Non-operating income							53			—
Foreign currency exchange (loss) gain							(641		)	3,496
Income before income taxes	27,492			24,101			28,582			27,492
Income tax expense	(869		)	(1,750		)	(2,126		)	(869		)
Net income including noncontrolling interest	26,623			22,351			26,456			26,623
Net income attributable to noncontrolling interest (see Note 8)	196			192			248			196
Net income attributable to Ebix, Inc.	$	26,427		$	22,159		$	26,208		$	26,427

Basic earnings per common share attributable to Ebix, Inc.	$	0.83		$	0.67		$	0.83		$	0.83

Diluted earnings per common share attributable to Ebix, Inc.	$	0.83		$	0.67		$	0.83		$	0.83

Basic weighted average shares outstanding	31,807			33,043			31,482			31,807

Diluted weighted average shares outstanding	31,973			33,310			31,659			31,973

See accompanying notes to the condensed consolidated financial statements.

Ebix, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income

(In thousands)

(Unaudited)


	Three Months Ended				Three Months Ended
	March 31,				March 31,
	2017		2016		2018			2017

Net income including noncontrolling interest	$	26,623	$	22,351	$	26,456		$	26,623
Other comprehensive income:
Foreign currency translation adjustments	2,517		1,657		(4,759		)	2,517
Total other comprehensive income	2,517		1,657
Total other comprehensive (loss) income					(4,759		)	2,517
Comprehensive income	29,140		24,008		21,697			29,140
Comprehensive income attributable to noncontrolling interest (see Note 8)	196		192		248			196
Comprehensive income attributable to Ebix, Inc.	$	28,944	$	23,816	$	21,449		$	28,944

See accompanying notes to the condensed consolidated financial statements.

Ebix, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(In thousands, except share amounts)


	March 31, 2017		December 31, 2016		March 31, 2018		December 31, 2017
ASSETS	(Unaudited)				(Unaudited)
Current assets:
Cash and cash equivalents	$	120,195	$	114,118	$	111,898	$	63,895
Short-term investments	3,260		3,105		18,356		25,592
Restricted cash	11,249		17,217		3,992		4,040
Trade accounts receivable, less allowances of $2,962 and $2,833, respectively	68,424		62,713
Fiduciary funds- restricted					8,645		8,035
Trade accounts receivable, less allowances of $5,138 and $4,143, respectively					117,443		117,838
Other current assets	13,896		12,716		30,533		33,532
Total current assets	217,024		209,869		290,867		252,932

Property and equipment, net	38,823		37,061		40,647		41,704
Goodwill	443,304		441,404		672,159		666,863
Intangibles, net	39,683		41,336		43,679		45,711
Indefinite-lived intangibles	30,887		30,887		42,055		42,055
Capitalized software development costs, net	6,108		5,955		8,659		8,499
Deferred tax asset, net	33,741		31,345		48,489		43,529
Other assets	5,620		5,898		15,889		11,720
Total assets	$	815,190	$	803,755	$	1,162,444	$	1,113,013

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities	$	23,948	$	44,855	$	77,231	$	75,073
Accrued payroll and related benefits	6,595		7,474		7,235		8,201
Short term debt, net of deferred financing costs of $136, respectively	12,364		12,364
Cash overdraft					9,941		9,243
Fiduciary funds- restricted					8,645		8,035
Short term debt, net of deferred financing costs of $449 and $136, respectively					13,824		14,364
Capital lease obligations	9		9		17		17
Current deferred rent	285		281
Deferred rent					205		278
Contingent liability for accrued earn-out acquisition consideration	1,943		1,921		4,000		4,000
Deferred revenue	23,643		22,564		27,492		22,562
Other current liabilities	276		244		10,085		5,159
Total current liabilities	69,063		89,712		158,675		146,932

Revolving line of credit	194,029		154,029		173,694		274,529
Long term debt and capital lease obligations, less current portion, net of deferred financing costs of $435 and $452, respectively	102,713		105,824
Long term debt and capital lease obligations, less current portion, net of deferred financing costs of $1,748 and $298, respectively					235,778		110,978
Other liabilities	7,005		6,070		11,632		11,658
Contingent liability for accrued earn-out acquisition consideration	6,810		6,589		32,511		33,096
Deferred revenue	1,342		1,886		8,822		1,423
Long term deferred rent	913		1,009
Deferred rent					405		638
Total liabilities	381,875		365,119		621,517		579,254

Commitments and Contingencies (see Note 5)

Stockholders’ equity:
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at March 31, 2017 and December 31, 2016	—		—
Common stock, $0.10 par value, 60,000,000 shares authorized, 31,524,369 issued and outstanding, at March 31, 2017 and 32,093,294 issued and outstanding at December 31, 2016	3,152		3,209
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at March 31, 2018 and December 31, 2017					—		—


Common stock, $0.10 par value, 120,000,000 shares authorized, 31,458,976 issued and outstanding, at March 31, 2018, 2017 and 120,000,000 shares authorized, 31,476,428 issued and outstanding at December 31, 2017							3,146			3,148
Additional paid-in capital	—			—			—			1,410
Retained earnings	448,621			457,364			523,668			510,975
Accumulated other comprehensive loss	(31,160		)	(33,677		)	(28,782		)	(24,023		)
Total Ebix, Inc. stockholders’ equity	420,613			426,896			498,032			491,510
Noncontrolling interest (see Note 8)	12,702			11,740			42,895			42,249
Total stockholders' equity	433,315			438,636			540,927			533,759
Total liabilities and stockholders’ equity	$	815,190		$	803,755		$	1,162,444		$	1,113,013

See accompanying notes to the condensed consolidated financial statements.

Ebix, Inc. and Subsidiaries

Condensed Consolidated Statements of Stockholders’ Equity

(unaudited)

(In thousands except for share figures)


	Common Stock																			Common Stock
	Issued Shares		Amount			Additional Paid-in Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Noncontrolling interest		Total			Issued Shares		Amount			Additional Paid-in Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Noncontrolling interest		Total

Balance, December 31, 2016	32,093,294		$	3,209		$	—		$	457,364		$	(33,677	)	$	11,740	$	438,636
Balance, January 1, 2018																				31,476,428		$	3,148		$	1,410		$	510,975		$	(24,023	)	$	42,249	$	533,759
Cumulative effect of accounting change (adoption of Topic 606), net of tax effect																				—		—			—			(8,802		)	—			—		$	(8,802	)
Cumulative effect of accounting change (adoption of ASC 340-40), net of tax effect																				—		—			—			(1,460		)	—			—		(1,460		)
Net income attributable to Ebix, Inc.	—		—			—			26,427			—			—		26,427			—		—			—			26,208			—			—		26,208
Net income attributable to noncontrolling interest (see Note 8)	—		—			—			—			—			196		196			—		—			—			—			—			248		248
Cumulative translation adjustment	—		—			—			—			2,517			—		2,517			—		—			—			—			(4,759		)	—		(4,759		)
Repurchase and retirement of common stock	(594,048	)	(59		)	(1,366		)	(32,742		)				—		(34,167		)	(30,000	)	(3		)	(1,339		)	(884		)	—			—		(2,226		)
Vesting of restricted stock	24,271		2			(2		)	—			—			—		—			13,274		1			(1		)	—			—			—		—
Exercise of stock options	3,500		—			52			—			—			—		52
Share based compensation	—		—			686			—			—			—		686			—		—			753			—			—			—		753
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested	(2,648	)	—			(167		)	—			—			—		(167		)	(726	)	—			(36		)	—			—			—		(36		)
Loans by non-controlling interest converted to capital contribution to joint venture	—		—			797			—			—			766		1,563
Recognized noncontrolling ownership of joint venture																				—		—			(787		)	—			—			398		(389		)
Dividends paid	—		—			—			(2,428		)	—			—		(2,428		)	—		—			—			(2,369		)	—			—		(2,369		)
Balance, March 31, 2017	31,524,369		$	3,152		$	—		$	448,621		$	(31,160	)	$	12,702	$	433,315
Balance, March 31, 2018																				31,458,976		$	3,146		$	—		$	523,668		$	(28,782	)	$	42,895	$	540,927

See accompanying notes to the condensed consolidated financial statements.

Ebix, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)


	Three Months Ended						Three Months Ended
	March 31,						March 31,
	2017			2016			2018			2017
Cash flows from operating activities:
Net income attributable to Ebix, Inc.	$	26,427		$	22,159		$	26,208		$	26,427
Net income attributable to noncontrolling interest	196			192			248			196
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,855			2,720
Amortization and depreciation							2,807			2,855
Benefit for deferred taxes	(850		)	(165		)	(1,874		)	(850		)
Share based compensation	686			647			753			686
Provision for doubtful accounts	407			(241		)	1,045			407
Unrealized foreign exchange gain	(860		)	(48		)
Unrealized foreign exchange loss (gain)							419			(860		)
Amortization of capitalized software development costs	410			326			525			410
Reduction of acquisition earnout accruals	—			(511		)
Purchase accounting adjustment	(948		)	—			—			(948		)
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable	(5,661		)	(8,669		)	(1,401		)	(5,661		)
Other assets	112			(220		)	(554		)	198
Accounts payable and accrued expenses	(7,118		)	(7,563		)	1,438			(7,118		)
Accrued payroll and related benefits	(1,021		)	717			(946		)	(1,021		)
Deferred revenue	382			1,258			(2,361		)	382
Deferred rent	(102		)	(80		)	(317		)	(102		)
Reserve for potential uncertain income tax return positions	518			50			30			518
Other liabilities	268			(38		)	(527		)	268
Net cash provided by operating activities	15,701			10,534			25,493			15,787

Cash flows from investing activities:
Acquisition of Transcorp							(6,554		)	—
Cash received from Paul Merchants for 10% stake in MTSS combined business							4,996			—
Capitalized software development costs	(514		)	(144		)	(622		)	(514		)
Purchases of marketable securities	(1,005		)	(596		)
Maturities (Purchases) of marketable securities							5,198			(1,005		)
Capital expenditures	(2,705		)	(1,028		)	(531		)	(2,705		)
Net cash used in investing activities	(4,224		)	(1,768		)
Net cash provided by (used in) investing activities							2,487			(4,224		)

Cash flows from financing activities:
Proceeds from revolving line of credit, net	40,000			20,000
(Repayments of) Proceeds from revolving line of credit, net							(100,835		)	40,000
Proceeds from term loan							124,250			—
Principal payments of term loan obligation	(3,125		)	—			—			(3,125		)
Repurchases of common stock	(40,517		)	(14,787		)	—			(40,517		)
Proceeds from the exercise of stock options	52			29			—			52
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested	(167		)	(66		)	(36		)	(167		)
Dividend payments	(2,428		)	(2,422		)	(2,369		)	(2,428		)
Cash Overdraft							745			—
Payments of capital lease obligations	(1		)	—			—			(1		)
Net cash provided by (used in) financing activities	(6,186		)	2,754			21,755			(6,186		)
Effect of foreign exchange rates on cash	786			321			(1,723		)	786
Net change in cash and cash equivalents	6,077			11,841
Cash and cash equivalents at the beginning of the period	114,118			57,179
Cash and cash equivalents at the end of the period	$	120,195		$	69,020
Net change in cash and cash equivalents, and restricted cash							48,012			6,163
Cash and cash equivalents, and restricted cash at the beginning of the period							70,867			116,941
Cash and cash equivalents, and restricted cash at the end of the period							$	118,879		$	123,104
Supplemental disclosures of cash flow information:
Interest paid	$	2,289		$	1,987		$	4,280		$	2,289
Income taxes paid	$	6,663		$	7,015		$	6,751		$	6,663

See accompanying notes to the condensed consolidated financial statements.

Supplemental schedule of noncash financing activities:

During the three months ended March 31, ~~2017~~2018 there were ~~2,648~~726 shares, totaling ~~$167~~$36 thousand, used to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vesting.

As of ~~December~~March 31, ~~2016~~2018 there were ~~109,475~~30,000 shares totaling ~~$6.4~~$2.2 million of share repurchases that were not settled until ~~January 2017.~~April 2018.

Ebix, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

Note 1: Description of Business and Summary of Significant Accounting Policies

Description of Business— Ebix, Inc., and its subsidiaries, (“Ebix” or the “Company”) is ana leading international supplier of on-demand ~~software and e-commerce solutions~~infrastructure Exchanges to the insurance, financial, and healthcare industries. In the insurance sector, the Company’s main focus is to develop and ~~financial industries, as well as e-governance~~deploy a wide variety of insurance and reinsurance exchanges on an on-demand basis, while also providing Software-as-a-Service ("SaaS") enterprise solutions ~~to governmental agencies~~ in the ~~health~~area of customer relationship management, front-end & back-end systems, outsourced administrative and education sectors. Ebix provides various application software products for the insurance industry including data exchanges, carrier systems, broker systems, and agency systems, and custom software development for business entities across the insurance industry.risk compliance. The Company's products feature fully customizable and scalable on-demand software ~~applications~~ designed to streamline the way insurance professionals manage distribution, marketing, sales, customer service, and accounting activities. With a "Phygital” strategy that combines physical distribution outlets in many Association of Southeast Asian Nations (“ASEAN”) countries to an Omni-channel online digital platform, the Company’s EbixCash Financial exchange portfolio encompasses leadership in areas of domestic & international money remittance, travel, pre-paid & gift cards, utility payments, etc., in emerging countries such as India. EbixCash through its travel portal Via.com is also one of Southeast Asia’s leading travel exchanges with distribution outlets and corporate clients processing millions of transactions every year. The Company has its headquarters in Johns Creek, Georgia and also conducts operating activities in Australia, Canada, India, ~~Dubai,~~ New Zealand, Singapore, United Kingdom, Brazil, Philippines, Indonesia, and ~~Brazil.~~United Arab Emirates. International revenue accounted for ~~34.0%~~53.9% and ~~25.7%~~34.0% of the Company’s total revenue for the three months ended March 31, ~~2017~~2018 and ~~2016~~,2017, respectively.

The Company’s revenues are derived from four product/service channels. Presented in the table below is the breakout of our revenue streams for each of those product/service channels for the three months ended March 31, ~~2017~~2018 and ~~2016.~~2017.


	Three Months Ended				Three Months Ended
	March 31,				March 31,
(dollar amounts in thousands)	2017		2016
(In thousands)					2018		2017
Exchanges	$	52,614	$	50,086	$	81,858	$	52,614
Broker Systems	3,788		3,212		3,610		3,788
Risk Compliance Solutions (“RCS”)	21,852		16,751		22,267		21,852
Carrier Systems	849		1,017		495		849
Totals	$	79,103	$	71,066	$	108,230	$	79,103

The Company is continuing to evaluate the classification of the 2017 acquisitions that collectively make up the EbixCash Financial Exchanges, refer to Part I, Item I Business in our Form 10-K for the year ended December 31, 2017. Currently these acquisitions are reported under the Exchange channel, but this classification is subject to change based on the conclusions of our continued evaluations.

Summary of Significant Accounting Policies

Basis of Presentation—The accompanying unaudited condensed consolidated financial statements and these notes have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and in accordance with U.S. Generally Accepted Accounting Principles ("GAAP") with the effect of inter-company balances and transactions eliminated. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP and SEC rules have been condensed or omitted as permitted by and pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. These unaudited condensed consolidated financial statements contain adjustments (consisting only of normal recurring items) necessary to fairly present the consolidated financial position of the Company and its consolidated results of operations and cash flows. Operating results for the three months ended March 31, ~~2017~~2018 and ~~2016~~2017 are not necessarily indicative of the results that may be expected for future quarters or the full year of ~~2017.~~2018. The condensed consolidated December 31, ~~2016~~2017 balance sheet included in this interim period filing has been derived from the audited financial statements at that date, but does not necessarily include all of the information and related notes required by GAAP for complete financial statements. These condensed interim financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2016~~2017.

Restricted Cash- As part of the ItzCash Card Limited ("ItzCash") acquisition, $4.0 million of the possible future contingent earn-out payments is being held in escrow accounts for the twelve month period following the effective date of the acquisition to ensure that the acquired business achieves the minimum specified annual gross revenue threshold, which if not achieved will result in said funds being returned to Ebix. Additionally, as part of the Wdev Solucoes em Technologia SA ("Wdev") acquisition, upfront cash consideration is being held in an escrow account for the thirty-eight month period following the effective date of the acquisition to ensure that the acquired business achieves the minimum specified annual net revenue threshold, which if not achieved will result in said funds being returned to Ebix. As of March 31, 2018 there is $3.0 million included in other long-term assets of the Company's Condensed Consolidated Balance Sheet.

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the statement of cash flows:



	Three Months Ended
	March 31,
(In thousands)	2018		2017
Cash and cash equivalents	$	111,898	$	120,195
Restricted cash	3,992		—
Restricted cash included in other long-term assets	2,989		2,909
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	$	118,879	$	123,104

Advertising—~~With the exception of certain direct-response costs, advertising costs are expensed as incurred.~~ Advertising costs amounted to $1.5 million and ~~$1.7~~$1.5 million in the first three months of ~~2017~~2018 and ~~2016,~~2017, respectively, and are included in sales and marketing expenses in the accompanying Condensed Consolidated Statements of Income. Under legacy US GAAP 340-20, direct response advertising was eligible for capitalization if certain conditions were met. During the first three months of 2017 ~~and 2016~~ reported sales and marketing expenses included $1.0 million ~~and $987 thousand, respectively,~~ of amortization of certain direct-response advertising costs associated with our medical education services, which have been capitalized in accordance with Accounting Standards Codification ("ASC") Topic 340. These costs ~~are being~~were previously amortized to advertising expense over periods ranging from twelve to twenty-four months based on the type of product the customer purchased. ~~Deferred~~Effective January 1, 2018 Subtopic 340-40 replaced that guidance to require the costs of direct-response advertising to be expensed as they are incurred or the first time the advertising takes place. The Company was required to recognize a cumulative effective change to opening retained earnings in the year of adoption of the standard. The Company recorded a one-time $1.9 million adjustment to retained earnings on January 1, 2018 and is expensing all future costs ~~amounted to $2.6 million and $2.8 million at March 31, 2017 and December 31, 2016, respectively, and are included in other current assets and other assets on~~from this date forward. Under the ~~consolidated balance sheet.~~new guidance Subtopic 340-40, the Company's expense increased by $217 thousand during the first three months of 2018 from what would have been recorded under legacy US GAAP 340-20.

Fair Value of Financial ~~Instrument—~~Instruments—The Company follows the relevant GAAP guidance concerning fair value measurements which provides a consistent framework to define, measure, and disclose the fair value of assets and liabilities in financial statements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction. This guidance establishes a three-level hierarchy priority for disclosure of assets and liabilities recorded at fair value. The ordering of priority reflects the degree to which objective data from external active markets are available to measure fair value. The classification of assets and liabilities within the hierarchy is based on whether the inputs to the valuation methodology used for measurement are observable or unobservable. The classifications are as follows:

Level 1 Inputs - Unadjusted quoted prices available in active markets for identical investments to the reporting entity at the measurement date.

Level 2 Inputs - Other than quoted prices included in Level 1 inputs, ~~that~~which are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

Level 3 Inputs - Unobservable inputs, which are used to the extent that observable inputs are not available, and used in situations where there is little or no market activity for the asset or liability and wherein the reporting entity makes estimates and assumptions related to the pricing of the asset or liability including assumptions regarding risk.

A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

As of March 31, ~~2017~~2018, the Company had the following financial instruments to which it had to consider fair values and had to make fair value assessments:

Short-term investments (commercial bank certificates of deposits and mutual funds), for which the fair values are measured as a Level 1 instrument.

Contingent accrued earn-out business acquisition consideration liabilities for which fair values are measured as Level 3 instruments. These contingent consideration liabilities were recorded at fair value on the acquisition date and are ~~remeasured~~re-measured quarterly based on the then assessed fair value and adjusted if necessary. The increases or decreases in the fair value of contingent consideration payable can result from changes in anticipated revenue levels and changes in assumed discount periods and rates. As the fair value measure is based on significant inputs that are not observable in the market, they are categorized as Level 3.

Other financial instruments not measured at fair value on the Company's unaudited condensed consolidated balance sheet at March 31, ~~2017~~2018 but which require disclosure of their fair values include: cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, accrued payroll and related benefits, capital lease obligations, and the revolving line of credit and term loan debt under the syndicated credit agreement facility with Regions Financial Corporation. The Company believes that the estimated fair value of such instruments at March 31, ~~2017~~2018 and December 31, ~~2016~~2017 approximates their carrying value as reported on the unaudited Condensed Consolidated Balance Sheet.

Additional information regarding the Company's assets and liabilities that are measured at fair value on a recurring basis is presented in the following tables:


	Fair Values at Reporting Date Using*									Fair Values at Reporting Date Using*
Descriptions	Balance, March 31, 2017		Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)			Balance, March 31, 2018		Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(In thousands)									(In thousands)
Assets
Available-for-sale securities:
Commercial bank certificates of deposits ($925 thousand is recorded in the long term asset section of the consolidated balance sheets in "Other Assets")	$	4,185	$	4,185	$	—	$	—
Commercial bank certificates of deposits ($4.23 million is recorded in the long term asset section of the consolidated balance sheets in "Other Assets")										$	22,588	$	22,588	$	—	$	—
Mutual Funds ($771 thousand recorded in the long term asset section of the consolidated balance sheets in "Other Assets")										771		771		—		—
Total assets measured at fair value	$	4,185	$	4,185	$	—	$	—		$	23,359	$	23,359	$	—	$	—

Liabilities
Derivatives:
Contingent accrued earn-out acquisition consideration (a)	$	8,753	$	—	$	—	$	8,753		$	36,511	$	—	$	—	$	36,511
Total liabilities measured at fair value	$	8,753	$	—	$	—	$	8,753		$	36,511	$	—	$	—	$	36,511

(a) The income valuation approach is applied and the valuation inputs include the contingent payment arrangement terms, projected cash flows, rate of return, and probability assessments.
* During the three months ended March 31, 2017 there were no transfers between fair value Levels 1, 2 or 3.
* During the three months ended March 31, 2018 there were no transfers between fair value Levels 1, 2 or 3.									* During the three months ended March 31, 2018 there were no transfers between fair value Levels 1, 2 or 3.


	Fair Values at Reporting Date Using*									Fair Values at Reporting Date Using*
Descriptions	Balance, December 31, 2016		Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)			Balance, December 31, 2017		Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(In thousands)									(In thousands)
Assets
Available-for-sale securities:
Commercial bank certificates of deposits ($970 thousand is recorded in the long term asset section of the consolidated balance sheets in "Other Assets")	$	4,030	4,030		$	—	$	—
Commercial bank certificates of deposits ($2.19 million is recorded in the long term asset section of the consolidated balance sheets in "Other Assets")										$	22,293	22,293		$	—	$	—
Mutual Funds ($785 thousand recorded in the long term asset section of the consolidated balance sheets in "Other Assets")										6,278		6,278		—		—
Total assets measured at fair value	$	4,030	$	4,030	$	—	$	—		$	28,571	$	28,571	$	—	$	—

Liabilities
Derivatives:
Contingent accrued earn-out acquisition consideration (a)	$	8,510	$	—	$	—	$	8,510		$	37,096	$	—	$	—	$	37,096
Total liabilities measured at fair value	$	8,510	$	—	$	—	$	8,510		$	37,096	$	—	$	—	$	37,096

(a) The income valuation approach is applied and the valuation inputs include the contingent payment arrangement terms, projected cash flows, rate of return, and probability assessments.
* During the twelve months ended December 31, 2016 there were no transfers between fair value Levels 1, 2 or 3.
* During the twelve months ended December 31, 2017 there were no transfers between fair value Levels 1, 2 or 3.									* During the twelve months ended December 31, 2017 there were no transfers between fair value Levels 1, 2 or 3.

For the Company's assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3), the following table provides a reconciliation of the beginning and ending balances for each category therein, and gains or losses recognized during the three months ended March 31, ~~2017~~2018 and during the year ended December 31, ~~2016:~~2017:

														Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Contingent Liability for Accrued Earn-out Acquisition Consideration		March 31, 2017		December 31, 2016				March 31, 2018			December 31, 2017
		(in thousands)						(In thousands)

Beginning balance		$	8,510	$	4,277			$	37,096		$	8,510

Total remeasurement adjustments:
Gains included in earnings **		—		(1,344		)		—			(164		)
Reductions recorded against goodwill		—		(664		)		—			(4,007		)
Foreign currency translation adjustments ***		243		(208		)		(585		)	522

Acquisitions and settlements
Business acquisitions		—		6,449				—			34,156
Settlement payments		—		—				—			(1,921		)

Ending balance		$	8,753	$	8,510			$	36,511		$	37,096

The amount of total (gains) losses for the period included in earnings or changes to net assets, attributable to changes in unrealized gains relating to assets or liabilities still held at period-end. Vertex earnout period expired in the third quarter of 2016 and gain was realized.		$	—	$	(624	)
The amount of total (gains) losses for the period included in earnings or changes to net assets, attributable to changes in unrealized gains relating to assets or liabilities still held at period-end.								$	—		$	—

** recorded as a reduction to reported general and administrative expenses	** recorded as a reduction to reported general and administrative expenses						** recorded as a reduction to reported general and administrative expenses
*** recorded as a component of other comprehensive income within stockholders' equity	*** recorded as a component of other comprehensive income within stockholders' equity						*** recorded as a component of other comprehensive income within stockholders' equity

Quantitative Information about Level 3 Fair Value Measurements

The significant unobservable inputs used in the fair value measurement of the Company's contingent consideration liabilities designated as Level 3 are as follows:

Sensitivity to Changes in Significant Unobservable Inputs

As presented in the table above, the significant unobservable inputs used in the fair value measurement of contingent consideration related to business acquisitions are projected revenue forecasts as developed by the relevant members of Company's management team and the probability of achievement of those revenue forecasts. Significant increases (decreases) in these unobservable inputs in isolation would result in a significantly higher (lower) fair value measurement. The Company applies these terms in its calculation and determination of the fair value of contingent earn out liabilities for purchased businesses as part of the related valuation and purchase price allocation exercise for the corresponding acquired assets and liabilities. During ~~2016,~~2017, certain of the Company's contingent earn out liabilities were adjusted because of changes to anticipated future revenues from these acquired businesses, or as a result of finalizing purchase price allocations that were previously provisional.

Revenue Recognition—In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 outlines a single comprehensive model for companies to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. In March 2016, the FASB issued ASU 2016-08, “Principal Versus Agent Considerations (Reporting Revenue Gross Versus Net),” which amends the principal-versus-agent implementation guidance and in April 2016 the FASB issued ASU 2016-10, “Identifying Performance Obligations and Licensing,” which amends the guidance in those areas in the new revenue recognition standard.

The Company derives its revenues primarily from subscription and transaction fees pertaining to services delivered over our exchanges or from our application service provider ("ASP") platforms, fees for risk compliance solution services, and fees for software development projects including associated fees for consulting, implementation, training, and project management provided to customers with installed systems and applications. Sales and value-added taxes are not included in revenues, but rather are recorded as a liability until the taxes assessed are remitted to the respective taxing authorities.

~~In accordance with Financial Accounting Standard Board (“FASB”) and SEC accounting guidance on~~Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.

We determine revenue recognition through the ~~Company considers revenue earned and realizable when: (a) persuasive evidence~~following steps:

identification of the ~~sales arrangement exists, provided that the arrangement fee is fixed~~contract, or ~~determinable, (b) delivery or performance has occurred, (c) customer acceptance has been received or is assured, if contractually required, and (d) collectability~~contracts, with a customer;

identification of the ~~arrangement fee is probable. The Company uses signed contractual agreements as persuasive evidence of a sales arrangement. We apply~~performance obligations in the ~~provisions~~contract;

determination of the ~~relevant generally accepted accounting principles related to all transactions involving~~transaction price;

allocation of the ~~license of software where the software deliverables are considered more than inconsequential~~transaction price to the ~~other elements~~performance obligations in the ~~arrangement.~~contract; and

recognition of revenue when, or as, we satisfy a performance obligation.

For contracts that contain multiple deliverables, we analyze the revenue arrangements in accordance with the relevant technical accounting guidance, which provides criteria governing how to determine whether goods or services that are delivered separately in a bundled sales arrangement should be considered as separate ~~units of accounting~~performance obligations for the purpose of revenue recognition. These types of arrangements include ~~deliverables~~obligations pertaining to software licenses, system set-up, and professional services associated with product customization or modification. Delivery of the various contractual ~~elements~~obligations typically occurs over periods of less than eighteen ~~months~~.months. These arrangements generally do not have refund provisions or have very limited refund terms.

Software development arrangements involving significant customization, modification or production are accounted for in accordance with the appropriate technical accounting guidance issued by FASB using the percentage-of-completion method. The Company recognizes revenue using periodic reported actual hours worked as a percentage of total expected hours required to complete the project arrangement and applies the percentage to the total arrangement fee.

Financial exchange revenue consists largely of transaction-based fees and fees from corporate and retail gift vouchers. The transaction-based fees are primarily based on a percentage of payment value processed for solutions such as retail and corporate payments, domestic money transfers, and general purpose reloadable cards. Transaction-based fees are recognized at the completion of the transaction. Gift voucher revenue is recognized at full purchase value at time of sale with the corresponding cost of vouchers recorded under direct expenses.

The Company adopted the new revenue recognition standard as of January 1, 2018 using the modified retrospective method and applying the new standard to those contracts which were not completed as of January 1, 2018. Therefore, the comparative financial information has not been restated and continues to be reported under the accounting standards in effect for those periods.

The adoption resulted in a decrease to retained earnings of $11.6 million for the cumulative effect of applying the Topic 606. This decrease was principally driven by the deferral of certain services revenues associated with programming, setup, and implementation activities related to our SaaS offering and changes related to costs to obtain customers, including the related amortization period.

Impact of New Revenue Recognition Standard on Financial Statement Line Items

The cumulative effect of applying the new guidance to all contracts was recorded as an adjustment to retained earnings as of the adoption date. As a result of applying the modified retrospective method to adopt the new revenue guidance, the following adjustments were made to accounts on the condensed consolidated balance sheet as of January 1, 2018:



	Impact of Change in Accounting Policy
(In thousands)	As Reported December 31, 2017		Adjustments			Adjusted January 1, 2018
Other Current Assets	$	33,532	$	898		$	34,430
Current Assets	252,932		898			253,830
Deferred tax asset, net	43,529		2,843			46,372
Other Assets	11,720		1,502			13,222
Total Assets	1,113,013		5,243			1,118,256
Current Deferred Revenue	22,562		5,124			27,686
Current Liabilities	146,932		5,124			152,056
Long Term Deferred Revenue	1,423		8,921			10,344
Total Liabilities	579,254		14,045			593,299
Retained Earnings	510,975		(8,802		)	502,173

The following tables present the impact of adopting Topic 606 on the Company’s unaudited consolidated financial statements for the three months ended March 31, 2018:



	Impact of Change in Accounting Policy
	As Reported March 31, 2018			Adjustments			Balances without adoption of Topic 606
Condensed Consolidated Statement of Income	(In thousands)
Operating Revenue	$	108,230		$	(623	)	$	107,607
Costs of Services Provided	39,591			(139		)	39,452
Total Operating Expenses	74,334			(139		)	74,195
Operating Income	33,896			(484		)	33,412
Income before income taxes	28,582			(484		)	28,098
Income tax (expense) benefit	(2,126		)	118			(2,008		)
Net income including noncontrolling interest	26,456			(366		)	26,090
Net income attributable to Ebix, Inc.	26,208			(366		)	25,842
Basic earnings per common share attributable to Ebix, Inc	0.83			(0.01		)	0.82
Diluted Earnings per common share attributable to Ebix, Inc	0.83			(0.01		)	0.82

Condensed Consolidated Balance Sheet
Other current assets	$	30,533		$	(870	)	$	29,663
Total current assets	290,867			(870		)	289,997
Deferred tax asset, net	48,489			(2,843		)	45,646
Other assets	15,889			(1,392		)	14,497
Total assets	1,162,444			(5,105		)	1,157,339
Current Deferred Revenue	27,492			(4,787		)	22,705
Total current liabilities	158,675			(4,787		)	153,888
Long Term Deferred Revenue	8,822			(7,565		)	1,257
Total liabilities	621,517			(12,352		)	609,165
Retained earnings	523,668			7,247			530,915

Condensed Consolidated Statement of Cash Flows
Net income attributable to Ebix, Inc.	$	26,208		$	(366	)	$	25,842
Other assets	(554		)	(139		)	(693		)
Deferred Revenue	(2,361		)	1,693			(668		)
Net cash provided by operating activities	25,493			1,188			26,681

Disaggregation of Revenue

The following tables present revenue disaggregated by primary geographical regions and product channels for the three months ended March 31, 2018:



	Three Months Ended March 31,
	(In thousands)
Revenue:	2018		2017⁽¹⁾
United States	$	49,902	$	52,179
Canada	1,600		2,108
Latin America	5,394		3,899
Australia	9,487		8,899
Singapore	2,216		1,731
New Zealand	487		480
India	32,003		5,620
Europe	4,031		4,187
Dubai	4		—
Indonesia	1,541		—
Philippines	1,348		—
United Arab Emirates	217		—
	$	108,230	$	79,103

See Note 7 for additional geographic information



	Three Months Ended
	March 31,
(In thousands)	2018		2017⁽¹⁾
Exchanges	$	81,858	$	52,614
Broker Systems	3,610		3,788
RCS	22,267		21,852
Carrier Systems	495		849
Totals	$	108,230	$	79,103

(1) Prior period amount have not been adjusted under the modified retrospective method.

Costs to Obtain and Fulfill a Contract

The Company capitalizes certain costs to obtain and fulfill a new contract and contract renewals. These costs are primarily related to the setup and customization of our SaaS based platforms and are amortized over the benefit period. Under our treatment prior to implementing Topic 606, these costs were expensed as incurred. As of March 31, 2018, the Company had $870 thousand of contract costs in “Other current assets” and $1.4 million in “Other Assets” on the Condensed Consolidated Balance Sheets.



	Three Months Ended
(In thousands)	March 31, 2018
Balance, beginning of period	$	—
Topic 606 adjustment	2,401
Adjusted beginning balance	$	2,401
Costs recognized from adjusted beginning balance	(240		)
Additions, net of costs recognized	101
Balance, end of period	$	2,262

Deferred Revenue

The Company records deferred revenue when it receives payments or invoices in advance of the performance of services. A significant portion of this balance relates to contracts where the customer has paid in advance for the use of our SaaS platforms over a specified period of time. This portion is recognized as the related performance obligation is fulfilled, generally less than one year. The remaining portion of the deferred revenue balance consists primarily of customer specific customizations that are not distinct from related performance obligations that transfer over time. This portion is recognized over the expected useful life of the customizations.



	Three Months Ended
(In thousands)	March 31, 2018
Balance, beginning of period	$	23,985
Topic 606 adjustment	14,045
Adjusted beginning balance	$	38,030
Revenue recognized from adjusted beginning balance	(12,560		)
Additions, net of revenue recognized	10,844
Balance, end of period	$	36,314

Practical Expedients and Exemptions

We do not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed, and (iii) contracts from periods prior to the application of Topic 606.

Income Taxes

The adoption of ASC 606 resulted in an increase to deferred revenue, which in turn generated an additional deferred tax asset that increased the Company’s net deferred tax asset position.

Accounts Receivable and the Allowance for Doubtful ~~Accounts Receivable—~~Accounts—Reported accounts receivable include $~~57.0~~85.4 million of trade receivables stated at invoice billed amounts and ~~$11.4~~$32.0 million of unbilled receivables ~~net~~(net of the estimated allowance for doubtful accounts receivable in the amount of $~~3.0~~5.1 million.) The unbilled receivables pertain to certain projects for which the timing of billing is tied to contractual milestones. The Company is continuing to evaluate the 2017 and first quarter 2018 acquisitions that collectively make up the EbixCash Financial Exchanges, refer to Part I, Item I Business in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, and their impact on our condensed consolidated balance sheets. The Company adheres to such contractually stated performance milestones and accordingly issues invoices to customers as per contract billing schedules. Approximately ~~$6.8~~$7.8 million of deferred revenue is included in billed accounts receivable at March 31, ~~2017. The~~2018. During the three months ending March 31, 2018 and 2017 the Company recognized and recorded bad debt expense ~~(benefit)~~ in the amount of $1.0 million and $407 thousand, ~~and $(241) thousand for the three-month periods ended March 31, 2017 and 2016,~~ respectively. Accounts receivable are written off against the allowance account when the Company has exhausted all reasonable collection efforts. During the three months ended March 31, 2018 and 2017, $40 thousand and $82 thousand, respectively, of accounts receivable, which had been specifically reserved for in prior periods, were written off.

Goodwill and Other Indefinite-Lived Intangible Assets—Goodwill represents the cost in excess of the fair value of the net assets of acquired businesses. Indefinite-lived intangible assets represent the fair value of certain acquired contractual customer

relationships for which future cash flows are expected to continue indefinitely. In accordance with the relevant FASB accounting guidance, goodwill and indefinite-lived intangible assets are not amortized but are tested for impairment at the reporting unit level on an annual basis or on an interim basis if an event occurs or circumstances change that would likely have reduced the fair value of a reporting unit below its carrying value. Potential impairment indicators include a significant change in the business climate, legal factors, operating performance indicators, competition, and the sale or disposition of a significant portion of the business. The impairment evaluation process involves an assessment of certain qualitative factors to determine whether the existence of events or circumstances would indicate that it is more likely than not that the fair value of any of our reporting units was less than its carrying amount. If after assessing the totality of events or circumstances, we were to determine that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company would not perform the two-step quantitative impairment testing described further below.

The aforementioned two-step quantitative testing process involves comparing the reporting unit carrying values to their respective fair values; we determine fair value of our reporting units by applying the discounted cash flow method using the present value of future estimated net cash flows. If the fair value of a reporting unit exceeds its carrying value, then no further testing is required. However, if a reporting unit's fair value were to be less than its carrying value, we would then determine the amount of the impairment charge, if any, which would be the amount that the carrying value of the reporting unit's goodwill exceeded its implied value. Projections of cash flows are based on our views of growth rates, operating costs, anticipated future economic conditions and the appropriate discount rates relative to risk and estimates of residual values. We believe that our estimates are consistent with assumptions that marketplace participants would use in their estimates of fair value. The use of different estimates or assumptions for our projected discounted cash flows (e.g., growth rates, future economic conditions, discount rates and estimates of terminal values) when determining the fair value of our reporting units could result in different values and may result in a goodwill impairment charge.

In 2016 the goodwill residing in the Broker Systems reporting unit and the Carrier Systems reporting unit, were evaluated for impairment based on an assessment of certain qualitative factors, and were determined not to have been impaired. In 20162017 the goodwill residing in the Exchange reporting unit, the RCS reporting unit, and the ~~Risk Compliance Solutions ("RCS")~~Carrier reporting unit were evaluated for impairment using step-one of the quantitative testing process described above. The fair value of ~~both~~three of these reporting units were found to be greater than their carrying value, and ~~thusly there was no need to proceed to~~thus step-two ~~as there was~~of the quantitative testing process described above became unnecessary because no impairment was indicated. In specific regards to the RCS reporting unit, its assessed fair value was ~~$130.0~~was $158.0 million which was ~~$36.8~~$42.4 million or ~~39%~~36.7% in excess of its ~~$93.2~~$115.6 million carrying value. Key assumptions used in the fair value determination were annual revenue growth of 5%7.5% to ~~15%~~12.5% and discount rate of ~~15%~~16%. As of September 30, ~~2016~~2017 there was ~~$68.3~~$78.2 million of goodwill assigned to the RCS reporting unit. A significant reduction in future revenues for the RCS reporting unit would negatively affect the fair value determination for this unit and may result in an impairment to goodwill and a corresponding charge against earnings. We perform our annual goodwill impairment evaluation and testing as of September 30th of each year. This evaluation is ~~done~~performed during the fourth quarter each year. During the year ended December 31, ~~2016~~2017 we had no impairment of our reporting unit goodwill balances.

Changes in the carrying amount of goodwill for the three months ended March 31, ~~2017~~2018 and the year ended December 31, ~~2016~~2017 are reflected in the following table.


						March 31, 2018			December 31, 2017
	March 31, 2017		December 31, 2016			(Unaudited)
	(In thousands)					(In thousands)
Beginning Balance	$	441,404	$	402,259		$	666,863		$	441,404
Additions (see Note 3)	—		35,787			7,254			233,095
Purchase accounting adjustments	948		4,298			1,528			(12,158		)
Foreign currency translation adjustments	952		(940		)	(3,486		)	4,522
Ending Balance	$	443,304	$	441,404		$	672,159		$	666,863

Capitalized Software Development Costs—In accordance with the relevant FASB accounting guidance regarding the development of software to be sold, leased, or marketed, the Company expenses such costs as they are incurred until technological feasibility has been established, at and after which time those costs are capitalized until the product is available for general release to customers. Costs incurred to enhance our software products, after general market release of the services using the products, are expensed in the period they are incurred.

Finite-lived Intangible Assets—Purchased intangible assets represent the estimated acquisition date fair value of customer relationships, developed technology, trademarks and non-compete agreements obtained in connection with the businesses we acquire. We amortize these intangible assets on a straight-line basis over their estimated useful lives, as follows:



Category		Life (yrs)
Customer relationships		7–20
Developed technology		3–12
Dealer networks		15-20
Trademarks		3–15
Non-compete agreements		5
Backlog		1.2
Database		10

The carrying value of finite-lived and indefinite-lived intangible assets at March 31, ~~2017~~2018 and December 31, ~~2016~~2017 are as follows:


							March 31, 2018			December 31, 2017
	March 31, 2017			December 31, 2016			(Unaudited)
	(In thousands)						(In thousands)
Finite-lived intangible assets:
Customer relationships	$	71,556		$	71,338		$	73,916		$	73,725
Developed technology	16,067			16,011			15,124			15,076
Dealer network							10,401			10,581
Trademarks	2,670			2,666			2,712			2,698
Non-compete agreements	764			764			764			764
Backlog	140			140			140			140
Database	212			212			212			212
Total intangibles	91,409			91,131			103,269			103,196
Accumulated amortization	(51,726		)	(49,795		)	(59,590		)	(57,485		)
Finite-lived intangibles, net	$	39,683		$	41,336		$	43,679		$	45,711

Indefinite-lived intangibles:
Customer/territorial relationships	$	30,887		$	30,887		$	42,055		$	42,055

Amortization expense recognized in connection with acquired intangible assets was $2.0 million and $1.9 million ~~and $1.7 million~~ for the three months ended March 31, ~~2017~~2018 and ~~2016,~~2017, respectively.

Foreign Currency Translation—The functional currency for the Company's foreign subsidiaries in India, Dubai, and Singapore is the U.S. dollar because the intellectual property research and development activities provided by its Dubai and Singapore subsidiaries, and the product development and information technology enabled services activities for the insurance industry provided by its India subsidiary, both in support of ~~Ebix's~~the Company's operating divisions across the world, are transacted in U.S. dollars.

The functional currency of the Company's other foreign subsidiaries is the local currency of the country in which the subsidiary operates. The assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at the rates of exchange at the balance sheet dates. Income and expense accounts are translated at the average exchange rates in effect during the period. Gains and losses resulting from translation adjustments are included as a component of accumulated other comprehensive income in the accompanying consolidated balance sheets, and are included in the condensed consolidated statements of comprehensive income. Foreign exchange transaction gains and losses that are derived from transactions denominated in a currency other than the subsidiary's functional currency are included in the determination of net income.

Income Taxes—Deferred income taxes are recorded to reflect the estimated future tax effects of differences between the financial statement and tax basis of assets, liabilities, operating losses, and tax credit carry forwards using the tax rates expected to be in effect when the temporary differences reverse. Valuation allowances, if any, are recorded to reduce deferred tax assets to the amount management considers more likely than not to be realized. Such valuation allowances are recorded for the portion of

the deferred tax assets that are not expected to be realized based on the levels of historical taxable income and projections for future taxable income over the periods in which the temporary differences will be deductible.

The Company also applies the relevant FASB accounting guidance on accounting for uncertainty in income taxes positions. This guidance clarifies the accounting for uncertainty in income taxes by prescribing the minimum recognition threshold a tax

position is required to meet before being recognized in the financial statements. In this regard we recognize the tax benefit from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.

The Company has applied the provisions under FASB update No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry Forward, A Similar Tax Loss, or a Tax Credit Carry Forward Exists. Under these provisions, an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carry forward, a similar tax loss, or a tax credit carry forward in most cases. This provision has been applied resulting in $341 thousand of unrecognized tax benefits that have been applied against both the NOL carry forward amounts as of March 31, 2017 and December 31, 2016.

Recent Relevant Accounting Pronouncements—The following is a brief discussion of recently released accounting pronouncements that are pertinent to the Company's business:

In February 2018, the FASB issued Accounting Standards Update ("ASU") 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The ASU provides that the stranded tax effects from the Tax Act in accumulated other comprehensive loss may be reclassified to retained earnings. The amendments in this Update are effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company has yet to assess the impact that the adoption of this ASU will have on Ebix's consolidated income statement and balance sheet.

In January 2017 the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350) Simplifying the Test for Goodwill Impairment". To simplify the subsequent measurement of goodwill, the FASB eliminated Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities). Instead, under the amendments in this ASU, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. A public business entity filer should adopt the amendments in this ASU for its annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. The Company has yet to assess the impact that the adoption of this ASU will have on Ebix's consolidated income statement and balance sheet.

In January 2017 the FASB issued ASU 2017-01, "Business Combinations (Topic 805) Clarifying the Definition of a Business" which amended the existing FASB Accounting Standards Codification. The standard provides additional guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The definition of a business affects many areas of accounting, including acquisitions, disposals, goodwill, and consolidation. ASU 2017-01 is effective for fiscal 2019 with early adoption permitted. The Company has yet to assess the impact that the adoption of this ASU will have on Ebix's consolidated income statement and balance sheet

In November 2016 the FASB issued ASU 2016-18, "Statement of Cash Flow (Topic 230) Restricted Cash" amends ASC 230 to add or clarify guidance on the classification and presentation of restricted cash in the statement of cash flows. The amendments in this Update require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The amendments in this Update should be applied using a retrospective transition method to each period presented. The Company adopted the new guidance on January 1, 2018 with no material impact to its statement of cash flows. For the three month ended March 31, 2018 and 2017, the Company held $4.0 million and zero, respectively, in "Restricted cash" and $3.0 million and $2.9 million, respectively, in "Other long-term assets" of the Company's Condensed Consolidated Balance Sheet.

In October 2016 the FASB issued ~~Accounting standards Update ("ASU")~~ASU 2016-16, "Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than ~~Inventory.~~Inventory". Current GAAP prohibits the recognition of current and deferred income taxes for an intra-entity asset transfer until the asset has been sold to an outside party. This prohibition on recognition is an exception to the principle of comprehensive recognition of current and deferred income taxes in GAAP. The amendments specified by ASU 2016-16 require an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. The amendments eliminate the exception for an intra-entity transfer of an asset other than inventory. Two common examples of assets included in the scope of the amendments are intellectual property, and property, plant and equipment. The amendments do not include new disclosure requirements; however, existing disclosure requirements might be applicable when accounting for the current and deferred income taxes for an intra-entity transfer of an asset other than inventory. The amendments align the recognition of income tax consequences for intra-entity transfers of assets other than inventory with International Financial Reporting Standards. IAS 12, Income Taxes, requires recognition of current and deferred income taxes resulting from an intra-entity transfer of any asset (including inventory) when the transfer occurs. The amendments are effective for public business entities for annual reporting periods beginning after December 15, 2017, including interim reporting periods within those annual reporting periods. Early adoption is permitted for all entities in the first interim period if an entity issues interim financial statements. The amendments

should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company ~~has yet~~adopted the new guidance on January 1, 2018 with no material impact to ~~assess the impact that the adoption of this ASU will have on Ebix's~~its consolidated ~~income statement and balance sheet.~~financial statements.

In August 2016 the FASB issued ASU No. 2016-15 “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments”. This ASU addresses the following eight specific cash flow issues: Contingent consideration payments made after a business combination; distributions received from equity method investees; debt prepayment or debt extinguishment costs; settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies and bank-owned life insurance policies; and beneficial interests in securitization transactions; and also addresses separately identifiable cash flows and application of the predominance principle. The amendments in this Update apply to all entities, including both business entities and not-for-profit entities that are required to present a statement of cash flows under Topic 230. The amendments are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The amendments should be applied using a retrospective transition method to each period presented. If it is impracticable to apply the amendments retrospectively for some of the issues, the ASU for those issuers would be applied prospectively as of the earliest date practicable. The Company ~~has yet~~adopted the new guidance on January 1, 2018 with no material impact to ~~assess the impact that the adoption of this ASU will have on Ebix's consolidated income statement and balance sheet.~~

~~In March 2016 the FASB issued ASU 2016-07 "Investments - Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting~~". The amendments affect all entities that have an investment that becomes qualified for the equity method of accounting as a result of an increase in the level of ownership interest or degree of influence. The amendments eliminate the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an investor must adjust the investment, results of operations, and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investment had been held. The amendments require that the equity method investor add the cost of acquiring the additional interest in the investee to the current basis of the investor’s previously held interest and adopt the equity method of accounting as of the date the investment becomes qualified for equity method accounting. Therefore, upon qualifying for the equity method of accounting, no retroactive adjustment of the investment is required. The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. The amendments should be applied prospectively upon their effective date to increases in the level of ownership interest or degree of influence that result in the adoption of the

~~equity method. Earlier application is permitted. The adoption of this ASU in the first quarter of 2017 did not impact our~~its consolidated financial ~~position, results of operations or cash flows.~~

~~In March 2016 the FASB issued ASU 2016-09~~, “~~Compensation - Stock Compensation (Topic 71~~8)”. This amendment simplifies the requirements for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. Several aspects of the accounting for share-based payment award transactions are simplified, including: (a) income tax consequences; (b) classification of awards as either equity or liabilities; and (c) classification on the statement of cash flows. The adoption of this ASU in the first quarter of 2017 did not impact our consolidated financial position, cash flows or resulting tax expense.statements.

In February 2016 the FASB issued ASU 2016-02, "Leases (Topic 842)". This new accounting guidance is intended to improve financial reporting about leasing transactions. The ASU affects all companies and other organizations that lease assets such as real estate, airplanes, and manufacturing equipment. The ASU will require organizations that lease assets referred to as “Lessees” to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. An organization is to provide disclosures designed to enable users of financial statements to understand the amount, timing, and uncertainty of cash flows arising from leases. These disclosures include qualitative and quantitative requirements concerning additional information about the amounts recorded in the financial statements. Under the new guidance, a lessee will be required to recognize assets and liabilities for leases with lease terms of more than twelve months. Consistent with current GAAP, the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee primarily will depend on its classification as a finance or operating lease. However, unlike current GAAP which requires only capital leases to be recognized on the balance sheet the new ASU will require both types of leases (i.e., operating and capital) to be recognized on the balance sheet. The FASB lessee accounting model will continue to account for both types of leases. The capital lease will be accounted for in substantially the same manner as capital leases are accounted for under existing GAAP. For operating leases there will have to be the recognition of a lease liability and a lease asset for all such leases greater than one year in term. The leasing standard will be effective for calendar year-end public companies beginning after December 15, 2018. Public companies will be required to adopt the new leasing standard for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted for all companies and organizations. For calendar year-end public companies, this means an adoption date of January 1, 2019 and retrospective application to previously issued annual and interim financial statements for 2018 and 2017. Lessees with a large portfolio of leases are likely to see a significant increase in balance sheet assets and liabilities. See Note 5 for the Company’s current lease commitments. The Company is evaluating the impact that this new leasing ASU will have on its financial statements.

~~In May 2014 the FASB issued ASU No. 2014-09, "Revenue from Contracts with Customer~~s". ASU 2014-09 affects any entity using U.S. GAAP that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). This ASU will supersede the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance. This ASU also supersedes some cost guidance included in Subtopic 605-35, Revenue Recognition—Construction-Type and Production-Type Contracts. In addition, the existing requirements for the recognition of a gain or loss on the transfer of nonfinancial assets that are not in a contract with a customer (e.g., assets within the scope of Topic 360, Property, Plant, and Equipment, and intangible assets within the scope of Topic 350, Intangibles—Goodwill and Other) are amended to be consistent with the guidance on recognition and measurement (including the constraint on revenue) in this ASU.

The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps:

~~Step 1: Identify the contract(s) with a customer.~~

~~Step 2: Identify the performance obligations in the contract.~~

~~Step 3: Determine the transaction price.~~

~~Step 4: Allocate the transaction price to the performance obligations in the contract.~~

~~Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.~~

For a public entity, the amendments in this ASU are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted.

~~An entity should apply the amendments in this ASU using one of the following two methods:~~

~~1. Retrospectively to each prior reporting period presented and the entity may elect any of the following practical expedients:~~

~~For completed contracts, an entity need not restate contracts that begin and end within the same annual reporting period.~~

For completed contracts that have variable consideration, an entity may use the transaction price at the date the contract was completed rather than estimating variable consideration amounts in the comparative reporting periods.

For all reporting periods presented before the date of initial application, an entity need not disclose the amount of the transaction price allocated to remaining performance obligations and an explanation of when the entity expects to recognize that amount as revenue.

2. Retrospectively with the cumulative effect of initially applying this ASU recognized at the date of initial application. If an entity elects this transition method it also should provide the additional disclosures in reporting periods that include the date of initial application of:

~~The amount by which each financial statement line item is affected in the current reporting period by the application of this ASU as compared to the guidance that was in effect before the change.~~

~~An explanation of the reasons for significant changes.~~

~~Subsequently, in August 2015 the FASB issued ASU No. 2015-14~~ ~~"Revenue from Contracts with Customers: Deferral of Effective Date~~", to defer the effective date of ASU No. 2014-09 for all entities by one year. Accordingly public business entities should apply the guidance of ASU 2014-09 to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that annual reporting period.

Although early adoption is allowed, the Company plans to adopt this new accounting standard on its newly revised effective date of January 1, 2018, but it has not presently determined the impact that the adoption of ASU No. 2014-09 will have on its income statement, balance sheet, or statement of cash flows. Furthermore, the Company has not yet determined the method of retrospective adoption it will use as described in first and second paragraphs immediately above.

~~In March 2016 the FASB issued Accounting Standards Update ("ASU") No. 2016-08, "Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net~~)". The amendments relate to when another party, along with the Company, is involved in providing a good or service to a customer. Topic 606 Revenue from Contracts with Customers requires an entity to determine whether the nature of its promise is to provide that good or service to the customer (i.e., the entity is a principal) or to arrange for the good or service to be provided to the customer by the other party (i.e., the entity is an agent). The amendments are intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations by clarifying the following:

~~>An entity determines whether it is a principal or an agent for each specified good or service promised to a customer.~~

~~> An entity determines the nature of each specified good or service (e.g., whether it is a good, service, or a right to a good or service).~~

> When another entity is involved in providing goods or services to a customer, an entity that is a principal obtains control of: (a) a good or another asset from the other party that it then transfers to the customer; (b) a right to a service that will be performed by another party, which gives the entity the ability to direct that party to provide the service to the customer on the entity’s behalf; or (c) a good or service from the other party that it combines with other goods or services to provide the specified good or service to the customer.

> The purpose of the indicators in paragraph 606-10-55-39 is to support or assist in the assessment of control. The amendments in paragraph 606-10-55-39A clarify that the indicators may be more or less relevant to the control assessment and that one or more indicators may be more or less persuasive to the control assessment, depending on the facts and circumstances.

The effective date and transition of these amendments is the same as the effective date and transition of ASU 2014-09, Revenue from Contracts with Customers (Topic 606). Public entities should apply the amendments in ASU 2014-09 for annual

reporting periods beginning after December 15, 2017, including interim reporting periods therein (i.e., January 1, 2018, for a calendar year entity). The Company will adopt this new technical accounting guidance at that time and does not expect its adoption to have a material effect on its result of operations or financial position.

~~In a related technical accounting pronouncement in April 2016 the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing”~~, which is an amendment to ASU 2014-09. This amendment provides clarification on two aspects of Topic 606: identifying performance obligations and the licensing implementation guidance. The effective date and transition requirements for the amendments are the same as the effective date and transition requirements in Topic 606. Public entities should apply the amendments for annual reporting periods beginning after December 15, 2017, including interim reporting periods therein (i.e., January 1, 2018, for a calendar year entity). Early application for public entities is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The effective date for nonpublic entities is deferred by one year. A summary of this ASU is as follows:

~~Identifying Performance Obligations~~

Before an entity can identify its performance obligations in a contract with a customer, the entity first identifies the promised goods or services in the contract. The amendments add the following guidance:

~~1. An entity is not required to assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.~~

2. An entity is permitted, as an accounting policy election, to account for shipping and handling activities that occur after the customer has obtained control of a good as an activity to fulfill the promise to transfer the good rather than as an additional promised service.

To identify performance obligations in a contract, an entity evaluates whether promised goods and services are distinct. The amendments improve the guidance on assessing the promises are separately identifiable criterion by:

1. Better articulating the principle for determining whether promises to transfer goods or services to a customer are separately identifiable by emphasizing that an entity determines whether the nature of its promise in the contract is to transfer each of the goods or services or whether the promise is to transfer a combined item (or items) to which the promised goods and/or services are inputs.

~~2. Revising the related factors and examples to align with the improved articulation of the separately identifiable principle.~~

~~Licensing Implementation Guidance~~

Topic 606 includes implementation guidance on determining whether an entity’s promise to grant a license provides a customer with either a right to use the entity’s intellectual property (which is satisfied at a point in time) or a right to access the entity’s intellectual property (which is satisfied over time). The amendments are intended to improve the operability and understandability of the licensing implementation guidance by clarifying the following:

1. An entity’s promise to grant a customer a license to intellectual property that has significant standalone functionality (e.g., the ability to process a transaction, perform a function or task, or be played or aired) does not include supporting or maintaining that intellectual property during the license period.

2. An entity’s promise to grant a customer a license to symbolic intellectual property (that is, intellectual property that does not have significant standalone functionality) includes supporting or maintaining that intellectual property during the license period.

3. An entity considers the nature of its promise in granting a license, regardless of whether the license is distinct, in order to apply the other guidance in Topic 606 to a single performance obligation that includes a license and other goods or services (in particular, the guidance on determining whether a performance obligation is satisfied over time or at a point in time and the guidance on how best to measure progress toward the complete satisfaction of a performance obligation satisfied over time).

Note 2: Earnings per Share

A reconciliation between basic and diluted earnings per share is as ~~follows (in thousands, except per share data):~~follows:


	Three Months Ended				Three Months Ended
	March 31,				March 31,
	2017		2016		2018		2017
	(In thousands, except per share data)				(In thousands, except per share data)
Net income attributable to Ebix, Inc.	$	26,427	$	22,159	$	26,208	$	26,427
Basic Weighted Average Shares Outstanding	31,807		33,043		31,482		31,807
Dilutive effect of stock options and restricted stock awards	166		267		177		166
Diluted weighted average shares outstanding	31,973		33,310		31,659		31,973
Basic earnings per common share	$	0.83	$	0.67	$	0.83	$	0.83
Diluted earnings per common share	$	0.83	$	0.67	$	0.83	$	0.83

Note 3: Business Combinations

The Company seeks to execute accretive business acquisitions (which primarily targets businesses that are complementary to Ebix's existing products and services), in combination with organic growth initiatives, as part of its comprehensive business growth and expansion strategy.

During the three months ended March 31, 2018, the Company completed one business acquisitions, as follows:

Effective February 1, 2018 Ebix acquired the Money Transfer Service Scheme ("MTSS") Business of Transcorp International Limited (BSE:TRANSCOR.BO), for upfront cash consideration in the amount of $7.25 million, of which $6.55 million was funded with cash and $700 thousand assumed in liabilities. Ebix is consolidating this recent acquisition into Ebix's Financial Exchange operations which will bring synergies and reduce certain redundancies to the combined operation. The valuation and purchase price allocation for the Transcorp acquisition remains preliminary and will be finalized as soon as practicable but in no event longer than one year from the effective date of this transaction.

During the twelve months ended December 31, 2017, the Company ~~had no business acquisitions.~~

~~During the year ended December 31, 2016, the Company~~ completed ~~three~~six business acquisitions, as follows:

Effective November 1, ~~2016~~2017 Ebix acquired ~~Wdev Solucoes em Technologia SA~~Via.com ("~~Wdev"~~Via"), a ~~Brazilian company that provides IT services~~recognized leader in the travel space in India and ~~software development for the Latin American insurance industry.~~an Omni-channel online travel and assisted e-commerce exchange. Ebix acquired ~~Wdev~~Via for upfront cash consideration in the amount $78.8 million plus possible future contingent payments of ~~$10.5~~up to $2.3 million based on any potential claims made by tax authorities over the subsequent twelve month period following the effective date of the acquisition and $2.0 million based on the receipt of refunds pertaining to certain advance tax payments and withholding taxes, both of which are included in "Other current liabilities" in the Company's Consolidated Balance Sheet. The valuation and purchase price allocation for the Via acquisition remains preliminary and will be finalized as soon as practicable but in no event longer than one year from the effective date of this transaction.

Effective November 1, 2017 Ebix acquired the MTSS Business of Paul Merchants, the largest international remittance service provider in India, for upfront cash consideration in the amount $37.4 million. The valuation and purchase price allocation for the Paul Merchants acquisition remains preliminary and will be finalized as soon as practicable but in no event longer than one year from the effective date of this transaction.

Effective October 1, 2017 Ebix acquired the MTSS Business of Wall Street, an inward international remittance service provider in India, along with the acquisition of its subsidiary company Goldman Securities Limited for upfront cash consideration in the amount $7.4 million. The valuation and purchase price allocation for the Wall Street acquisition remains preliminary and will be finalized as soon as practicable but in no event longer than one year from the effective date of this transaction.

YouFirst acquisition remains preliminary and will be finalized as soon as practicable but in no event longer than one year from the effective date of this transaction.

Effective June 1, 2017 Ebix acquired the assets of beBetter Health, Inc., ("beBetter"), a technology enabled corporate wellness provider that provides end-to-end wellness solutions offering a variety of tools and programs, including interactive platforms, health screening, coaching, tobacco cessation, weight and stress management, health information, and numerous other products and services. Ebix acquired the assets and intellectual property of beBetter for $1.0 million plus possible future contingent earn-out payments of up to ~~$15.7~~$2.0 million based on earned revenues over the subsequent ~~thirty-eight~~twenty-four month period following the effective date of the acquisition.

Effective April 1, 2017 Ebix entered into a joint venture with India-based Essel Group, while acquiring an 80% stake in ItzCash Card Limited ("ItzCash"), India’s leading payment solutions exchange. ItzCash is recognized as a leader in the prepaid cards and bill payments space in India. Under the terms of the agreement, ItzCash was valued at a total enterprise value of approximately $150 million. Accordingly, Ebix acquired an 80% stake in ItzCash for $120 million including upfront cash of $76.3 million plus possible future contingent earn-out payments of up to $44.0 million based on earned revenues over the subsequent thirty-six month period following the effective date of the acquisition. ~~$2.9~~$4.0 million of the ~~upfront cash consideration~~possible future contingent earn-out payments is being held in an escrow ~~account~~accounts for the ~~thirty-eight~~twelve month period following the effective date of the acquisition to ensure that the acquired business achieves the minimum specified annual ~~net~~gross revenue threshold, which if not achieved will result in said funds being returned to Ebix. The Company has determined that the fair value of the contingent earn-out consideration is $34.0 million as of March 31, 2018. The valuation and purchase price allocation for the ~~Wdev~~ItzCash acquisition remains preliminary and will be finalized as soon as practicable but in no event longer than one ~~year.~~

~~Effective November 1, 2016 Ebix acquired~~year from the ~~assets~~effective date of IHAC, Inc., d.b.a Hope Health ("Hope"), a Michigan corporation and publisher of health and wellness continuing education products. Ebix acquired the assets and intellectual property of Hope for $1.72 million. The valuation and purchase price allocation for the Hope acquisition remains preliminary and will be finalized prior to June 30, 2017.this transaction.

Effective July 1, 2016 Ebix and Independence Holdings Corporation ("IHC") jointly executed a Call Notice agreement, whereby Ebix purchased additional common units in Ebix Health Exchange Holdings, LLC ("EbixHealth JV") from IHC constituting eleven percent (11%) of the EbixHealth JV for $2.0 million cash which resulted in Ebix holding an aggregate fifty-one percent (51%) controlling equity interest in the EbixHealth JV. Commensurate with additional equity stake in the joint venture a contemporaneous valuation of the business was completed. In accordance with the technical accounting guidance pertaining to step acquisitions the Company recorded goodwill in the amount of $20.8 million, intangible assets in the amount of $1.5 million, a non-controlling interest in the amount of $11.3 million, and recognized a $1.2 million gain on its previously carried 40% equity interest in the EbixHealth JV. This recognized gain is reflected as a component of other non-operating income in the accompanying Condensed Consolidated Statement of Income. The valuation and purchase price allocation for the EbixHealth JV acquisition remains preliminary and will be finalized prior to June 30, 2017. Previously, effective September 1, 2015 Ebix and IHC formed a joint venture named EbixHealth JV. Ebix paid $6.0 million and contributed a license to use certain CurePet software and systems valued by the EbixHealth JV at $2.0 million, for its initial 40% membership interest in the EbixHealth JV.

A significant component of the purchase price consideration for many of the Company's business acquisitions is a potential subsequent cash earnout payment based on reaching certain specified future revenue targets. The terms for the contingent earn out payments in most of the Company's business acquisitions typically address the GAAP recognizable revenues achieved by the acquired entity over a one, two, and/or three year period subsequent to the effective date of their acquisition by Ebix. These terms typically establish a minimum threshold revenue target with achievement of revenues recognized over that target being awarded in the form of a specified cash earn out payment. The Company applies these terms in its calculation and determination of the fair value of contingent earn out liabilities for purchased businesses as part of the related valuation and purchase price allocation exercise for the corresponding acquired assets and liabilities. The Company recognizes these potential obligations as contingent liabilities and are reported as such on its Condensed Consolidated Balance Sheets. As discussed in more detail in Note 1, these contingent consideration liabilities are recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary. During the three months ended March 31, ~~2017~~2018 and ~~2016,~~2017, these aggregate contingent accrued earn-out business acquisition consideration liabilities were reduced by zero and ~~$511 thousand,~~zero, respectively, due to remeasurements based on the then assessed fair value and changes in anticipated future revenue levels. In the first ~~quarter of 2016~~three months ended March 31, 2018 and 2017 these reductions to the contingent accrued earn-out liabilities resulted in a corresponding reduction of ~~$511 thousand~~zero and zero, respectively to general and administrative expenses as reported on the Condensed Consolidated Statements of Income and a reduction of zero and zero, respectively to goodwill as reported in the enclosed Condensed Consolidated Balance Sheets. As of March 31, ~~2017,~~2018, the total of these contingent liabilities was ~~$8.75~~$36.5 million, of which ~~$6.81~~$32.5 million is reported in long-term liabilities, and ~~$1.94~~$4.0 million is included in current liabilities in the Company's Condensed Consolidated Balance Sheet. As of December 31, ~~2016~~2017 the total of these contingent liabilities was ~~$8.51~~$37.1 million, of which ~~$6.59~~$33.1 million was reported in long-term liabilities, and ~~$1.92~~$4.0 million was included in current liabilities in the Company's Condensed Consolidated Balance Sheet.

Consideration paid by the Company for the businesses it purchases is allocated to the assets and liabilities acquired based upon their estimated fair values as of the date of the acquisition. The excess of the purchase price over the estimated fair values of assets acquired and liabilities assumed is recorded as goodwill. Recognized goodwill pertains to the value of the expected synergies to be derived from combining the operations of the businesses we acquire including the value of the acquired workforce.

The aggregated unaudited pro forma financial information pertaining to all of the Company's acquisitions that have an impact on the three months ended March 31, ~~2017~~2018 and March 31, ~~2016,~~2017, which includes the acquisitions of the ~~EbixHealth JV (being fully consolidated effective July 1, 2016)~~ItzCash (acquired April 2017), ~~Wdev~~beBetter (acquired June 2017), YouFirst (acquired September 2017), WallStreet (acquired October 2017), Paul Merchants (acquired November ~~2016)~~2017), ~~and Hope~~Via (acquired November ~~2016),~~2017) and Transcorp (acquired February 2018) and as presented in the table below is provided for informational purposes only and is not a projection of the Company's expected results of operations for any future period. No effect has been given in this pro forma information for future synergistic benefits that may still be realized as a result of combining these companies or costs that may yet be incurred in integrating their operations. The ~~2017~~2018 and ~~2016~~2017 pro forma financial information below assumes that all such business acquisitions were made on January 1, ~~2016,~~2017, whereas the Company's reported financial statements for the three months ended March 31, ~~2017~~2018 only include the operating results from these businesses since the effective date that they were acquired by Ebix.


	Three Months Ended March 31, 2017				Three Months Ended March 31, 2016				Three Months Ended March 31, 2018				Three Months Ended March 31, 2017
	As Reported		Pro Forma		As Reported		Pro Forma		As Reported		Pro Forma		As Reported		Pro Forma
	(unaudited)				(unaudited)				(unaudited)				(unaudited)
	(In thousands, except per share data)								(In thousands, except per share data)
Revenue	$	79,103	$	79,103	$	71,066	$	77,099	$	108,230	$	108,818	$	79,103	$	111,849
Net Income attributable to Ebix, Inc.	$	26,427	$	26,427	$	22,159	$	22,136	$	26,208	$	26,267	$	26,427	$	28,340
Basic EPS	$	0.83	$	0.83	$	0.67	$	0.67	$	0.83	$	0.83	$	0.83	$	0.89
Diluted EPS	$	0.83	$	0.83	$	0.67	$	0.66	$	0.83	$	0.83	$	0.83	$	0.89

During the three months ended March 31, ~~2017~~2018 the Company's reported total operating revenues increased by ~~$8.0~~$29.1 million or ~~11%~~37% to ~~$79.1~~$108.2 million as compared to ~~$71.1~~$79.1 million during the same period in ~~2016.~~2017.

With respect to business acquisitions completed during the years ~~2017~~2018 and ~~2016~~2017 on a pro forma basis, as disclosed in the above pro forma financial information table, combined revenues ~~increased 3%~~decreased 2.7% for the three months ending March 31, ~~2017~~2018 versus the same ~~period~~periods in ~~2016.~~2017. The ~~2017~~2018 and ~~2016~~2017 pro forma financial information assumes that all business acquisitions made during this period were made on January 1, ~~2016,~~2017, whereas the Company's reported financial statements for ~~Q1 2017 and Q1 2016~~three months ended March 31, 2018 only

includes the revenues from these businesses since the effective date that they were acquired or consolidated by Ebix, being ~~July 2016~~April 2017 for ~~the EbixHealth JV,~~Itzcash, June 2017 for beBetter, September 2017 for YouFirst, October 2017 for WallStreet. November ~~2016~~2017 for ~~Wdev,~~Paul Merchants, November 2017 for Via, and ~~November 2016~~February 2018 for ~~Hope.~~Transcorp.

The above referenced pro forma information and the relative comparative change in pro forma and reported revenues are based on the following premises:

•~~2017~~2018 and ~~2016~~2017 pro forma revenue contains actual revenue of the acquired entities before acquisition date, as reported by the sellers, as well as actual revenue of the acquired entities after acquisition, whereas the reported growth in revenues of the acquired entities after acquisition date are only reflected for the period after their acquisition.

•Revenue billed to existing clients from the cross selling of acquired products has been assigned to the acquired section of our business.

•Any existing products sold to new customers obtained through a newly acquired customer base are assigned to the acquired section of our business.

•Pro formas do not include post acquisition revenue reductions as a result of discontinuation of any product lines and/or customer projects by Ebix in line with the Company's initiatives to maximize profitability.

Note 4: Debt with Commercial Bank

On February 21, 2018, Ebix, Inc. and certain of its subsidiaries entered into the Sixth Amendment (the “Sixth Amendment”) to the Regions Secured Credit Facility, dated August 5, 2014, among the Company, Regions Bank as Administrative and Collateral Agent ("Regions") and certain other lenders party thereto (as amended, the "Credit Agreement"). The Sixth Amendment amends the Credit Agreement by increasing its existing credit facility from $450 million to $650 million, to assist in funding its growth. The increase in the bank line was the result of many members of the existing bank group expanding their share of the credit facility and the addition of BBVA Compass and Bank West to the Banking Syndicate, which diversifies Ebix’s lending group under the credit facility to ten participants.The syndicated bank group now comprises ten leading financial institutions that include Regions Bank, PNC Bank, BMO Harris Bank, BBVA Compass, Fifth Third Bank, KeyBank, Bank West, Silicon Valley Bank, Cadence Bank and Trustmark National Bank. Regions Bank continued to lead the banking group while serving as the administrative and collateral agent. PNC Bank and BMO Harris Bank were added as co syndication agents, BBVA Compass and Fifth Third Bank as co documentation agent, while Regions Capital Markets, PNC Capital Markets and BMO Harris Bank acted as joint lead arrangers and joint bookrunners. The new credit facility has the following key components; A five-year term loan for $250 million,

with initial repayments starting June 30, 2018 due in the amount $3.13 million for the first eight quarters and increasing thereafter and a five-year revolving credit facility for $400 million. The new credit facility, also, allows for up to $150 million of incremental facilities. The Credit Agreement carries a leverage-based LIBOR related interest rate, which currently stands at approximately 3.88%.

On November 3, 2017 the Company and certain of its subsidiaries entered into the Fifth Amendment (the “Fifth Amendment”) to the Credit Agreement to exercise $50 million of its aggregate $100 million accordion option, increasing the total Term Loan Commitment to $175 million. $20 million of the increase was funded on November 3, 2017 and the remaining $30 million shall be disbursed upon the satisfaction of certain closing requirements set forth in the Fifth Amendment. Both such disbursements are tied to permitted acquisitions as set forth in the Fifth Amendment.

On November 3, 2017, the Company and certain of its subsidiaries entered into the Fourth Amendment and Waiver (the “Fourth Amendment”) to the Credit Agreement. The Fourth Amendment waives certain technical defaults related to the failure to give required notice with respect to i) the existence of a subsidiary having intellectual property with an aggregate value above a stipulated amount and ii) the additional investment in a joint venture entity resulting in that entity becoming a subsidiary of the Company for the purpose of the Credit Agreement. In addition to such waiver, the Fourth Amendment also loosened the leverage ratios the Company is required to satisfy in connection with permitted acquisitions and for compliance generally.

On October 19, 2017, the Company and certain of its subsidiaries entered into the Third Amendment and Waiver (the “Third Amendment”) to the Credit Agreement. The Third Amendment waives certain technical defaults related to the Company’s making certain restricted payments in excess of those permitted under the Credit Agreement. In addition to such waiver, the Third Amendment also loosened the limitations on the restricted payment covenant under the Credit Agreement.

On June 17, 2016, the Company and certain of its subsidiaries entered into the Second Amendment (the “Second Amendment”) to the ~~Regions Secured~~ Credit ~~Facility (as defined below), dated August 5, 2014, among the Company, Regions Bank as Administrative and Collateral Agent ("Regions"),~~Agreement, Regions Capital Markets, PNC Capital Markets, LLC, and TD Securities (USA) as joint Lead Arrangers for the syndicate of ~~lenders.~~lenders (the “Regions Secured Credit Facility”). The Second Amendment increases the total credit facility to $400 million from the prior amount of $240 million, and expands the syndicated bank group to eleven participants by adding seven new participants which include PNC Bank, National Association BMO Harris Bank N.A., Key Bank National Association, HSBC Bank National, Cadence Bank, the Toronto-Dominion Bank (New York Branch), and Trustmark National Bank. The Credit Agreement ~~(as defined below)~~ now consists of a five-year revolving credit component in the amount of $275 million, and a five-year term loan component in the amount of $125 million, with repayments due in the amount $3.13 million due each quarter, starting September 30, 2016 . The Credit Agreement also contains an accordion feature, which if exercised and approved by all credit parties, would expand the total borrowing capacity under the syndicated credit facility to $500 million. ~~The credit facility carries a leverage-based LIBOR related interest rate, which currently stands at approximately 3.06%.~~

As of March 31, ~~2017~~2018 the Company's consolidated balance sheet includes ~~$3.00~~$5.7 million of remaining deferred financing costs in connection with this credit facility, which are being amortized as a component of interest expense over the five-year term of the financing agreement. In regards to these deferred financing costs, ~~$2.4~~$3.5 million pertains to the revolving line of credit component of the Credit Agreement, and ~~$571 thousand~~$2.2 million pertains to the term loan component of the Credit Agreement of which ~~$136~~$449 thousand is netted against the current portion and ~~$435 thousand~~$1.7 million is netted against the long-term portions of the term loan as reported on the Condensed Consolidated Balance.

At March 31, ~~2017,~~2018, the outstanding balance on the revolving line of credit under the Credit Agreement was ~~$194.0~~$173.7 million and the facility carried an interest rate of ~~3.06%~~3.88%. During the three months ended March 31, ~~2017, $40.0~~2018, $20.0 million of draws were made off of the revolving credit facility. The revolving line of credit balance is included in the long-term liabilities section of the Condensed Consolidated Balance Sheets. During the three months ended March 31, ~~2017,~~2018, the average and maximum outstanding balances of the revolving line of credit component of the credit facility were ~~$160.2~~$224.2 million and ~~$194.0~~$274.5 million, respectively.

At March 31, ~~2017,~~2018, the outstanding balance on the term loan was ~~$115.6~~$250.0 million of which $12.5 million is due within the next twelve months, with ~~a payment of $3.13 million~~no payments having been made during the three months ended March 31, ~~2017, as scheduled.~~2018. This term loan also carried an interest rate of ~~3.06%~~3.88%. The current and long-term portions of the term loan are included in the respective current and long-term sections of the Condensed Consolidated Balance Sheets, the amounts of which were $12.5 million and ~~$103.1~~$237.5 million respectively at March 31, ~~2017.~~2018.

Note 5: Commitments and Contingencies

Contingencies- Following the announcement on May 1, 2013 of the Company's execution of a merger agreement with affiliates of Goldman Sachs & Co., twelve putative class action complaints challenging the proposed merger were filed in the

Delaware Court of Chancery. These complaints ~~name~~named as Defendants some combination of the Company, its directors, Goldman Sachs & Co. and affiliated entities. On June 10, 2013, the twelve complaints were consolidated by the Delaware Court of Chancery, now captioned In re Ebix, Inc. Stockholder Litigation, CA No. 8526-VCS. On June 19, 2013, the Company announced that the merger agreement had been terminated pursuant to a Termination and Settlement Agreement dated June 19, 2013. After Defendants moved to dismiss the consolidated proceeding, ~~Lead~~ Plaintiffs Desert States Employers & UFCW Union Pension Plan and Gilbert C. Spagnola (collectively, “Lead Plaintiffs”) amended their operative complaint to drop their claims against Goldman Sachs & Co. and focus their allegations on an Acquisition Bonus Agreement (“ABA”) between the Company and Robin Raina. On September 26, 2013, Defendants moved to dismiss the Amended Consolidated Complaint. On July 24, 2014, the Court issued its Memorandum Opinion that granted in large part the Company’s Motion to Dismiss and narrowed the remaining claims. On September 15, 2014, the Court entered an Order implementing its Memorandum Opinion. On January 16, 2015, the Court entered an Order permitting Plaintiffs to file a Second Amended and Supplemented Complaint. On February 10, 2015, Defendants filed a Motion to Dismiss the Second Amended and Supplemented Complaint, which was granted in part and denied in part in a January 15, 2016 Memorandum Opinion and Order. On October 25, 2016, the Court entered an Order permitting Lead Plaintiffs to file a Verified Third Amended and Supplemented Class Action and Derivative Complaint, which made additional claims and added two directors as defendants. The Verified Third Amended and Supplemented Class Action and Derivative Complaint was then filed on October 26, 2016. On October 31, 2016, Lead Plaintiffs filed a Motion for Class Certification. On November 1, 2016, Lead Plaintiffs moved for partial summary judgment on Claims (ii), (iii), and (vi) as described below. The directors added as defendants in the Third Amended and Supplemented Class Action and Derivative Complaint moved to dismiss all Claims against them. The remaining Defendants moved to dismiss certain Claims, and filed answers to the other claims in the Verified Third Amended and Supplemented Complaint. On December 12, 2017, the Court postponed the pending hearing on the Plaintiffs’ Motion for Class Certification and the Defendants’ motions to dismiss and, instead, granted the Plaintiffs leave to file a Verified Fourth Amended and Supplemented Class Action and Derivative Complaint, which pleading was filed on January 19, 2018. The claims in the fourth amended complaint are as follows: (i) a purported class and derivative claim for breach of fiduciary duty for improperly maintaining the ABA as an unreasonable anti-takeover device; (ii) a purported class claim for breach of the fiduciary duty of disclosure to the stockholders with respect to the Company’s 2010 Proxy Statement and 2010 Stock Incentive Plan; (iii) a purported derivative claim for breach of fiduciary duty to the Company in causing incentive compensation to be awarded under the 2010 Stock Incentive Plan; (iv) a purported class and derivative claim for breach of fiduciary duty in adopting certain bylaw amendments on December 19, 2014; (v) a purported class and derivative claim seeking invalidation of the December 19, 2014 bylaw amendments under Delaware law; (vi) a purported claim for breach of fiduciary duty for not duly adopting the ABA at the July 15, 2009 Board meeting, and seeking declaratory relief invalidating the ABA; (vii) a purported claim for breach of the fiduciary duty of disclosure to the stockholders with respect to the ABA, and seeking declaratory relief invalidating the ABA; (viii) a purported claim seeking invalidation of the 2008 Stockholder Meeting, 2008 Certificate Amendment, 2008 Stock Split and subsequent corporate actions; ~~and,~~ (ix) a purported class claim for breach of fiduciary duty, and seeking declaratory relief invalidating the 2016 CEO Bonus Plan because of incomplete disclosures with respect to the ABA; and (x) for breach of fiduciary duty and declaratory judgment relating to the interpretation of the ABA. Lead Plaintiffs seek declaratory relief with respect to the ABA, the 2010 Stock Incentive Plan, the 2010 Proxy Statement, the bylaw amendments, the 2008 Stockholder Meeting, the 2008 Certificate Amendment, the 2008 Stock Split, and the 2016 CEO Bonus Plan. Lead Plaintiffs also seek compensatory damages, interest, and attorneys’ fees and ~~costs. On October 31. 2016, Lead Plaintiffs filed a Motion~~costs, all in unspecified amounts. A trial is scheduled for Class Certification. On November 1, 2016, Lead Plaintiffs moved for partial summary judgment on Claims (ii), (iii), and (vi) as described above. The directors added as defendants in the Third Amended and Supplemented Class Action and Derivative Complaint moved to dismiss all Claims against them. The remaining Defendants moved to dismiss Claims (v), (vi), (vii), (viii), and (ix) as described above, and have filed answers to the other claims in the Verified Third Amended and Supplemented Complaint. Briefing schedules for the pending motions have not been yet set and discovery is on-going.August 2018. The Company denies any liability and intends to defend the action vigorously.

The Company is involved in various other claims and legal actions arising in the ordinary course of business. In the opinion of management, the ultimate likely disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position, results of operations or liquidity.

Lease Commitments—The Company leases office space under non-cancelable operating leases with expiration dates ranging through 2029, with various renewal options. Capital leases range from three to five years and are primarily for computer equipment. There were multiple assets under various individual capital leases at March 31, ~~2017~~2018 and ~~2016.~~2017. Rental expense for office facilities and certain equipment subject to operating leases for the three months ended March 31, ~~2017~~2018 and ~~2016~~2017 was ~~$790~~$1.9 million and $790 thousand (net of a ~~$948~~$(948) thousand purchase accounting adjustment) ~~and~~ ~~$1.5 million~~, respectively.

Business Acquisition Earn-out Contingencies-A significant component of the purchase price consideration for many of the Company's business acquisitions is a potential future cash earn-out based on reaching certain specified future revenue targets. The terms for the contingent earn-out payments in most of the Company's business acquisitions typically address the GAAP recognizable revenues achieved by the acquired entity over a one, two, and/or three year period subsequent to the effective date of their acquisition by Ebix. These terms typically establish a minimum threshold revenue target with achievement of revenues recognized over that target being awarded in the form of a specified cash earn-out payment. The Company applies these terms in its calculation and determination of the fair value of contingent earn-out liabilities for purchased businesses as part of the related valuation and purchase price allocation exercise for the corresponding acquired assets and liabilities. As of March 31, 2018, the total of these

contingent liabilities was $36.5 million, of which $32.5 million is reported in long-term liabilities, and $4.0 million is included in current liabilities in the Company's Condensed Consolidated Balance Sheet. As of December 31, 2017, the total of these contingent liabilities was $37.1 million, of which $33.1 million is reported in long-term liabilities, and $4.0 million is included in current liabilities in the Company's Condensed Consolidated Balance Sheet.

Self-Insurance—For some of the Company’s U.S. employees the Company is self-insured for its health insurance program and has a stop loss policy that limits the individual liability to $120 thousand per person and the aggregate liability to 125% of the expected claims based upon the number of participants and historical claims. As of March 31, ~~2017,~~2018, the amount accrued on the Company’s Condensed Consolidated Balance Sheet for the self-insured component of the Company’s employee health insurance was ~~$315~~$332 thousand. The maximum potential estimated cumulative liability for the annual contract period, which ends in September ~~2017,~~2019, was $2.8 million.

Note 6: Income Taxes

year, exclusive of discrete charges, due to ~~favorable changes in~~a new minimum tax on global intangible low-taxed income (“GILTI”) earned by foreign subsidiaries as part of the ~~proportion of our taxable income in certain foreign jurisdictions relative to total pre-tax income.~~Tax Act. The Company expects its full year tax rate before discrete items to be approximately ~~1.26%~~7.35%.

On December 22, 2017, the U.S. enacted the Tax Act, which implemented a number of changes that took effect on January 1, 2018, including but not limited to, a new minimum tax on GILTI earned by foreign subsidiaries. The Company estimated the impact of GILTI on the expected annual effective income tax rate and recorded a provisional tax expense. Any adjustment of the Company’s provisional tax expense will be reflected as a change in estimate in its results in the period in which the change in estimate is made in accordance with Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act, which is also included in ASU 2018-05, Income Taxes (Topic 740), Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 issued March 2018. In addition, the Company continues to gather information to compute the amount of the Transition Tax under the Tax Act and expects to finalize its calculation prior to filing its U.S. federal tax return, which is due October 15, 2018.

The Company’s effective tax rate reflects the benefits of having significant operations outside the United States, which are generally taxed at rates lower than the US statutory rate of ~~35%~~21% and where the Company enjoys a tax holiday in India. During 2015, the Company secured an additional tax holiday in India until the year 2020 to support certain portions of its expanding operations there. The Company, also, had income during the quarter ended March 31, ~~2017~~2018 in ~~Singapore,~~ the United Kingdom, Dubai, and Sweden, where the statutory tax rates are lower than the US rate of ~~35%~~21%.

As of March 31, ~~2017~~2018 a liability of ~~$3.8~~$9.2 million for uncertain tax positions is included in other long-term liabilities of the Company's Condensed Consolidated Balance Sheet. During the three months ended March 31, ~~2017~~2018 there was ~~$518~~$30 thousand in additions to this liability reserve. During the same periods in ~~2016,~~2017, there were ~~$50~~$518 thousand in additions to this liability reserve. The Company recognizes interest accrued and penalties related to unrecognized tax benefits as part of income tax expense.

Note 7: Geographic Information

The Company operates with one reportable segment whose results are regularly reviewed by the Company's CEO, its chief operating decision maker as to performance and allocation of resources. External customer revenues in the tables below are attributed to a particular country based on whether the customer had a direct contract with the Company which was executed in that particular country for the sale of the Company's products/services with an Ebix subsidiary located in that country.

The impact from fluctuations of the exchange rates for the foreign currencies in the countries in which we conduct operations partially affected reported revenues, and were the primary cause for the drop in revenues in Europe and the increase in Australia. Specifically, during

During the first three months of ~~2017~~2018 the ~~change~~United States' revenues decreased $2.3 million due primarily to a combination of decreased professional services and a seasonal decrease of continuing medical education services. Canada's revenues decreased by $508 thousand due primarily to decreased professional services. Latin America's revenues increased $1.5 million due primarily due to increased professional services. Australia's revenues increased by $588 thousand primarily due to a combination of increased professional services and transaction fees, and a $340 thousand increase due to changes in foreign currency exchange ~~rates decreased reported Europe's operating revenues by $655 thousand and increased Australia's reported revenues by $423 thousand; while~~rates. India's revenue increased ~~$3.6~~$26.4 million of which $1.2 million is due ~~primarily~~ to the various new e-governance contracts with a number of large ~~clients; Latin America's revenues increased $2.7~~

clients and $25.0 million due ~~primarily~~to its 2017 acquisitions of ItzCash (Q2 2017), YouFirst (Q3 2017), Wall Street (Q4 2017), Paul Merchants (Q4 2017), Via (Q4 2017) and the Q1 2018 acquisition of Transcorp. Increases in Indonesia, Philippines and United Arab Emirates are due to the November ~~2016~~2017 acquisition of ~~Wdev; and Canada's revenues increased by $1.3 million due primarily to increased professional services.~~Via.

The following ~~enterprise wide~~enterprise-wide information relates to the Company's geographic ~~locations (all amounts in thousands):~~

~~As of and for the Three Months Ended~~ ~~March 31, 2017~~locations:

United States Canada Latin America Australia Singapore New Zealand India Europe Dubai Total
External Revenues $ 52,179
$ 2,108
$ 3,899
$ 8,899
$ 1,731
$ 480
$ 5,620
$ 4,187
$ —
$ 79,103
Long-lived assets $ 385,474
$ 6,389
$ 24,374
$ 1,290
$ 17,457
$ 216
$ 87,301
$ 21,696
$ 53,969
$ 598,166



	As of and for the Three Months Ended March 31, 2018				As of and for the Three Months Ended March 31, 2017
	External Revenues		Long-lived assets		External Revenues		Long-lived assets
	(In thousands)
United States	$	49,902	$	396,775	$	52,179	$	385,474
Canada	1,600		6,381		2,108		6,389
Latin America	5,394		22,499		3,899		24,374
Australia	9,487		1,713		8,899		1,290
Singapore	2,216		17,950		1,731		17,457
New Zealand	487		289		480		216
India	32,003		344,568		5,620		87,301
Europe	4,031		27,317		4,187		21,696
Dubai	4		53,396		—		53,969
Indonesia	1,541		109		—		—
Philippines	1,348		550		—		—
United Arab Emirates	217		30		—		—
	$	108,230	$	871,577	$	79,103	$	598,166

~~As of and for the Three Months Ended~~ ~~March 31, 2016~~

United States Canada Latin America Australia Singapore New Zealand India Europe Dubai Total
External Revenues $ 52,796
$ 847
$ 1,137
$ 7,792
$ 1,434
$ 391
$ 2,026
$ 4,643
$ —
$ 71,066
Long-lived assets $ 372,004
$ 6,968
$ 6,708
$ 171
$ 68,718
$ 221
$ 76,789
$ 26,567
$ —
$ 558,146

In the geographical information table above the significant changes to long-lived assets from March 31, ~~2016~~2017 to March 31, ~~2017~~2018 were comprised of ~~a net $13.5 million~~an increase in the ~~U.S.~~United States of $8.0 million primarily due to fully consolidating the operations of the EbixHealth JV into the Company's financial statements; the Latin America increase of $17.7 million is primarily due to the November 2016 acquisition of Wdev; the Australia increase of $1.1 million is primarily due to the purchase of equipment to support its data exchange facilities; the Singapore decrease of $51.3 millioncapitalized continuing medical education product costs and the Dubai increase $54.0 million are due to the transfer of certain intangible assets between these locations (net of deferred taxes); the India increase of $10.5 million is primarily due an increase in deferred tax assets of $6.7 million associated with the payments and accruals of Minimum Alternative Tax, and $3.3 million of fixed assets additions associated with the continued build out of our ~~product development facilities, and the growth~~global corporate headquarters campus in Johns Creek, Georgia. A decrease in Latin America of ~~the Ebix-Vayam JV; and the Europe decrease of $4.9~~$1.9 million is primarily due to a ~~15.0%~~4.8% weakening of ~~British Pound Sterling~~the Brazilian Real versus the

U.S. Dollar which caused a $1.2 million decrease in the translation of long-lived assets and amortization of intangible assets. An increase in India of $257.3 million is primarily due to a $253.2 million increase associated with the 2017 acquisitions of ItzCash (Q2 2017), YouFirst (Q3 2017), Wall Street (Q4 2017), Paul Merchants (Q4 2017), Via (Q4 2017) and the Q1 2018 acquisition of Transcorp. The Europe increase of $5.6 million is primarily due to a 12.2% strengthening of the British Pound Sterling versus the U.S. Dollar which caused a $2.7 million increase in the translation of long-lived assets, an increase in deferred tax assets of $4.3 million primarily due to the release of valuation allowances of operating loss carryforwards, partially offset by the amortization of intangible assets and capitalized software development costs.

Note 8: Investment in Joint Ventures

Effective January 2, 2018 Paul Merchants acquired a 10% equity interest in Ebix’s combined international remittance business in India (comprised of YouFirst, Wall Street , Paul Merchants, and Transcorp) for cash consideration of $5.0 million. The consolidation of these acquisitions into Ebix's Financial Exchange operations will bring synergies and reduce certain redundancies to the combined operation. As part of this agreement Ebix retains an irrevocable option to reacquire 10% of the equity interest after one year at a predetermined price which is included in other current liabilities of the Company's Condensed Consolidated Balance Sheet.

Effective April 1, 2017 Ebix entered into a joint venture with India-based Essel Group, while acquiring an 80% stake in ItzCash, India’s leading payment solutions exchange. ItzCash is recognized as a leader in the prepaid cards and bill payments space in India. Under the terms of the agreement, ItzCash was valued at a total enterprise value of approximately $150 million. Accordingly, Ebix acquired an 80% stake in ItzCash for $120 million including upfront cash of $76.3 million plus possible future

contingent earn-out payments of up to $44.0 million based on earned revenues over the subsequent thirty-six month period following the effective date of the acquisition. $4.0 million of the possible future contingent earn-out payments is being held in escrow accounts for the twelve month period following the effective date of the acquisition to ensure that the acquired business achieves the minimum specified annual gross revenue threshold, which if not achieved will result in said funds being returned to Ebix. The valuation and purchase price allocation for the ItzCash acquisition remains preliminary and will be finalized as soon as practicable but in no event longer than one year.

Effective February 7, 2016 Ebix and Vayam Technologies Ltd ("Vayam") formed a joint venture named Ebix Vayam Limited JV. This joint venture was established to carry out IT projects in the government sector of the country of India and particularly in regards to the implementation of e-governance projects in the areas of education and healthcare. Ebix has a 51% equity interest in the joint venture, and Vayam has a 49% equity interest in the joint venture. Ebix is fully consolidating the operations of the Ebix Vayam Limited JV into the Company's financial statements and separately reporting the Vayam minority, non-controlling, interest in the joint venture's net income and equity.

Effective September 1, 2015 Ebix and IHC formed the joint venture EbixHealth JV (as defined in Note 3). This joint venture was established to promote and market an administrative data exchange for health and pet insurance lines of business nationally. Ebix paid $6.0 million and contributed a license to use certain CurePet software and systems valued by the EbixHealth JV at $2.0 million, for its initial 40% membership interest in the EbixHealth JV. IHC contributed all if its shares in its existing third party administrator operations (IHC Health Solutions, Inc.), valued by the EbixHealth JV at ~~$18.0~~$12.0 million for its 60% membership interest in the EbixHealth JV, and received a special distribution of $6.0 million. Effective July 1, 2016 Ebix and IHC jointly executed a Call Notice agreement, whereby Ebix purchased additional common units in the EbixHealth JV from IHC constituting eleven percent (11%) of the EbixHealth JV for $2.0 million cash which resulted in Ebix holding an aggregate fifty-one percent (51%) of the EbixHealth JV. Commensurate with additional equity stake in the joint venture and a new contemporaneous valuation of the business the Company realized a $1.2 million gain on its previously carried 40% equity interest in the EbixHealth JV. This recognized gain was reflected as a component of other non-operating income in the accompanying Condensed Consolidated Statement of Income. ~~The valuation and purchase price allocation for the EbixHealth JV acquisition remains preliminary and will be finalized prior to June 30, 2017.~~ Beginning July 1, 2016 Ebix is fully consolidating the operations of the EbixHealth JV into the Company's financial statements and separately reporting the IHC minority, non-controlling, 49% interest in the joint venture's net income and equity, and thereby reflecting Ebix's net resulting 51% interest in the EbixHealth JV profits or losses. IHC is, also, a customer of the EbixHealth JV, and during the three months ending March 31, 2018 and 2017 the EbixHealth JV recognized $2.3 million and $2.6 million, respectively, of revenue from IHC, and as of March 31, 2018 the EbixHealth JV had $1.0 million of accounts receivable from IHC. Furthermore, as a related party, IHC also has been and continues to be a customer of Ebix, and during the three ~~months~~ ending March 31, 2018 and 2017 the Company recognized $0 thousand and $97 thousand of revenue from IHC, and as of March 31, ~~2017~~2018 IHC had ~~$125~~$23 thousand of accounts receivable with Ebix.

Note 9: Capitalized Software Development Costs

In accordance with the relevant ~~FASB~~authoritative accounting literature the Company ~~had previously~~has capitalized certain software and product related development costs associated with both ~~its~~the Company’s continuing medical education service offerings, and the Company’s development of aits property and casualty underwriting insurance data exchange ~~platform.~~platform servicing the London markets. During the three months ended March 31, 2018 and 2017, respectively, the Company capitalized $622 thousand and $514 thousand of such development costs. As of March 31, 2018 and December 31, 2017 , a total of ~~$6.1~~$8.7 million and $8.5 million, respectively, of remaining unamortized development costs are reported on the Company’s consolidated balance sheet. During the three months ended March 31, 2018 and 2017, the Company recognized $525 thousand and $410 thousand, respectively, of amortization expense with regards to these capitalized software development costs, which is included in costs of services provided in the Company’s consolidated income statement. The ~~useful life over which these~~capitalized continuing medical education product costs are being amortized using a three-year to five-year straight-line methodology and certain continuing medical education products costs are immediately expensed. The capitalized software development costs ~~are being amortized is five years for both the continuing medical education products, and~~ for the property and casualty underwriting insurance data exchange ~~platform.~~

platform are being amortized over a period of five years.

Note 10: Other Current Assets

Other current assets at March 31, ~~2017~~2018 and December 31, ~~2016~~2017 consisted of the following:


					March 31, 2018		December 31, 2017
	March 31, 2017		December 31, 2016		(Unaudited)
	(In thousands)				(In thousands)
Prepaid expenses	$	11,716	$	10,276	$	26,074	$	29,347
Sales taxes receivable from customers					—		2,218
Due from prior owners of acquired businesses for working capital settlements	768		916		280		284
Research and development tax credits receivable	377		375
Accrued interest receivable	155		372		315		515
Tax refunds receivable	177		—		2,522		—
Credit card merchant account balance receivable					1,076		1,008
Other	703		777		266		160
Total	$	13,896	$	12,716	$	30,533	$	33,532

Note 11: Concentrations of Credit Risk

Credit Risk

The Company is potentially subject to concentrations of credit risk in its accounts receivable. Credit risk is the risk of an

unexpected loss if a customer fails to meet its contractual obligations. Although the Company is directly affected by the financial condition of its customers and the loss of or a substantial reduction in orders or the ability to pay from the customer could have a material effect on the consolidated financial statements, management does not believe significant credit risks exist at March 31, 2018. The Company had one customer whose accounts receivable balances individually represented 10% or more of the Company’s total accounts receivable.

Major Customer

As previously disclosed in Note 8, effective February 7, 2016 Ebix and Vayam Technologies Ltd ("Vayam") formed a

joint venture named Ebix Vayam Limited JV. This joint venture was established to carry out IT projects in the government sector of the country of India and particularly in regards to the implementation of e-governance projects in the areas of education and healthcare. Ebix has a 51% equity interest in the joint venture, and Vayam has a 49% equity interest in the joint venture. Ebix is fully consolidating the operations of the Ebix Vayam Limited JV into the Company's financial statements and separately reporting the Vayam minority, non-controlling, interest in the joint venture's net income and equity. Vayam is also a customer of the Ebix Vayam Limited JV, and during the three months ending March 31, 2018 and 2017 the Ebix Vayam Limited JV recognized $6.2 million and $5.0 million of revenue from Vayam, respectively, and as of March 31, 2018 the Ebix Vayam Limited JV had $28.4 million of accounts receivable with Vayam.

Note 11: Subsequent Events

Acquisition Bonus Agreement and SAR Agreement

On April 10, 2018, the Company entered into a Stock Appreciation Right Award Agreement (the “SAR Agreement”) with Robin Raina, the Company’s Chairman, President and Chief Executive Officer. The SAR Agreement replaced the Acquisition Bonus Agreement (the “ABA”) between the Company and Mr. Raina, dated July 15, 2009.

Amendment to Bank Credit Facility

On April 9, 2018, the Company and certain of its subsidiaries entered into the Seventh Amendment and Waiver (the “Seventh Amendment”) to the Credit Agreement. The Seventh Amendment increased the allowed indebtedness in the form of unsecured convertible notes of up to $250 million to $300 million at any time outstanding.

Acquisitions and Joint Ventures

On April 19, 2018 the Company announced that it has entered into an agreement to acquire a 60% stake in India based Smartclass Educational Services Private Limited (Smartclass), a leading e-learning Company engaged in the business of education services, development of education products, and implementation of education solutions for K-12 Schools. Under the terms of the agreement, Ebix will pay up to $8 million in cash for its stake in SmartClass.

On April 3, 2018 the Company announced that it has entered into an agreement to acquire India based CentrumDirect Limited (CDL), a leader in India’s Foreign exchange and outward remittance markets for approximately $175 million. CDL will be tightly integrated into Ebix’s Financial Exchange EbixCash offering in India and abroad, with key CDL business executives becoming an integral part of the combined EbixCash senior leadership. the agreement while approved by the Centrum Board, is subject to its shareholders and other regulatory/commercial approvals.

Item 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

As used herein, the terms “Ebix,” “the Company,” “we,” “our” and “us” refer to Ebix, Inc., a Delaware corporation, and its consolidated subsidiaries as a combined entity, except where it is clear that the terms mean only Ebix, Inc.

Safe Harbor for Forward-Looking Statements—This Form 10-Q and certain information incorporated herein by reference contains forward-looking statements and information within the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. This information includes assumptions made by, and information currently available to management, including statements regarding future economic performance and financial condition, liquidity and capital resources, acceptance of the Company’s products by the market, and management’s plans and objectives. In addition, certain statements included in this and our future filings with the SEC, in press releases, and in oral and written statements made by us or with our approval, which are not statements of historical fact, are forward-looking statements. Words such as “may,” “could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “seeks,” “plan,” “project,” “continue,” “predict,” “will,” and other words or expressions of similar meaning are intended by the Company to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are found at various places throughout this report and in the documents incorporated herein by reference. These statements are based on our current expectations about future events or results and information that is currently available to us, involve assumptions, risks, and uncertainties, and speak only as of the date on which such statements are made.

Our actual results may differ materially from those expressed or implied in these forward-looking statements. Factors that may cause such a difference include, but are not limited to, those discussed in Part I, Item 1A, “Risk Factors” in our Form 10-K for the year ended December 31, ~~2016~~2017 which is incorporated by reference herein and identified, and in Part II, Item 1A "Risk Factors" ~~for the three months ended March 31, 2017~~ in this Form 10-Q, as well as: the willingness of independent insurance agencies to outsource their computer and other processing needs to third parties; pricing and other competitive pressures and the Company’s ability to gain or maintain share of sales as a result of actions by competitors and others; changes in estimates in critical accounting judgments; changes in or failure to comply with laws and regulations, including accounting standards, taxation requirements (including tax rate changes, new tax laws and revised tax interpretations) in domestic or foreign jurisdictions; exchange rate fluctuations and other risks associated with investments and operations in foreign countries (particularly in Australia, Asia, Latin America, and Europe wherein we have significant and/or growing operations); fluctuations in the equity markets, including market disruptions and significant interest rate fluctuations, which may impede our access to, or increase the cost of, external financing; and international conflict, including terrorist acts. The Company undertakes no obligation to update any such factors, or to publicly announce the results of, or changes to any of the forward-looking statements contained herein to reflect future events, developments, changed circumstances, or for any other reason.

Other important factors that could cause actual results to differ materially from those in our specific forward-looking statements included in this Form 10-Q include, but are not limited to, the following:

Our ability to efficiently and effectively integrate acquired business operations, as discussed in Note 3 of the Condensed Notes to the Condensed Consolidated Financial Statements pertaining to the business acquisitions we have made;

Note 4 of the Notes to the Condensed Consolidated Financial Statements, "Debt with Commercial Bank" and our future liquidity needs discussed under “Liquidity and Financial Condition” regarding our ability to generate cash from operating

activities and any declines in our credit ratings or financial condition which could restrict our access to the capital markets or materially increase our financing costs;

Note 5 of the Notes to the Condensed Consolidated Financial Statements, “Commitments and Contingencies”, and “Contractual ~~Obligations and Commercial Commitments”~~Obligations” in ~~Managements~~Management's Discussion and Analysis of Financial Condition and Results of Operation ("MD&A") regarding uncertainties pertaining to the actual ultimate cost of our legal contingencies;

MD&A and the analysis of the three month revenue trends regarding actual realized level of demand for our products during the immediately foreseeable future, and fluctuations thereof.

Readers should carefully review the disclosures and the risk factors described in this and other documents we file from time to time with the SEC, including future reports on Forms 10-Q and 8-K, and any amendments thereto. You may obtain our SEC filings at our website, www.ebix.com under the “Investor Information” section, or over the Internet at the SEC’s website, www.sec.gov.

The following information should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in Part 1, Item 1 of this Quarterly Report, and the audited consolidated financial statements and notes thereto and MD&A contained in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2016~~2017.

Company Overview

Ebix ~~Inc.~~ is a ~~global~~leading international supplier of ~~software and e-commerce solutions~~on-demand infrastructure exchanges to the insurance, financial, and healthcare ~~industries, as well as e-governance~~industries. In the Insurance sector, the Company’s main focus is to develop and deploy a wide variety of insurance and reinsurance exchanges on an on-demand basis, while also, providing SaaS enterprise solutions ~~to governmental agencies~~ in the ~~health~~area of CRM, front-end & back-end systems, outsourced administrative and ~~education sectors. Ebix provides~~risk compliance.

With a ~~variety~~"Phygital” strategy that combines 231,500 physical distribution outlets in many ASEAN countries to an Omni-channel online digital platform, the Company’s EbixCash Financial exchange portfolio encompasses leadership in areas of ~~application software products for the insurance industry including carrier systems, broker systems, agency systems~~domestic & international money remittance, travel, pre-paid & gift cards, utility payments, etc., in an emerging country like India. EbixCash, through its travel portal Via.com, is also one of Southeast Asia’s leading travel exchanges with over 110,000 distribution outlets and ~~data exchanges to custom software development for all entities involved in insurance and financial services. Our~~8,000 corporate clients processing over 24.5 million transactions every year.

Ebix's goal is to be the leading ~~provider~~powerhouse of ~~back-end~~ insurance ~~transaction processing~~and financial transactions in the world. The Company’s technology vision is to focus on the convergence of ~~technology platforms for~~ all ~~insurance~~ channels, processes and entities in a manner such that data seamlessly flows once a data entry has initially been made. ~~Our customers include many of the top insurance sector companies in the world.~~

The insurance industry continues to undergo significant consolidation driven by the need for, and benefits from, economies of scale and scope in providing insurance services in a competitive environment. Such consolidation has involved both insurance carriers and insurance brokers and is directly impacting the manner in which insurance products are distributed. In particular the insurance industry has continued to experience an increase in initiatives designed to reduce paper-based processes and to improve efficiency both at the back-end and consumer-end sides. Management believes the insurance industry will continue to experience significant change and increased efficiencies through online exchanges. Changes in the insurance industry are expected to create new opportunities for the Company.

Ebix strives to work collaboratively with clients to develop innovative technology strategies and solutions that address specific business ~~challenges.~~challenges and requirements. Ebix combines the newest technologies with its capabilities in consulting, systems design and integration, IT and business process outsourcing, applications software, and ~~Web~~web and application hosting to meet the individual needs of ~~insurance providers and related entities. We intend to continue to expand both organically and through strategic business acquisitions.~~organizations.

Offices and Geographic Information

The Company has its worldwide headquarters in Johns Creek, Georgia with its international operations being managed from its Singapore offices, and it also has domestic operations in Santa Barbara, Pasadena and Hemet, California; Miami, Florida; Pittsburgh, Pennsylvania; Salt Lake City, Utah; Grove City, Ohio; Bohemia, New York; Norwalk and New Britain, Connecticut; Portland, Michigan; Birmingham, Alabama; Iselin, New Jersey as well as an additional operations office in Johns Creek, Georgia. The Company also has multiple operating facilities and offices in Australia, Brazil, Thailand, New Zealand, the United Kingdom, Canada, Singapore, Dubai, and India. In these operating offices, Ebix employs insurance and technology professionals who provide products, services, support and consultancy to thousands of customers across six continents.

Results of Operations — Three Months Ended March 31, ~~2017~~2018 and ~~2016~~2017

Operating Revenue

The Company derives its revenues primarily from subscription and transaction fees pertaining to services delivered over our exchanges or from our ~~ASP~~application service provider (“ASP”) platforms, fees for business process outsourcing services, and fees for software development projects including associated fees for consulting, implementation, training, and project management provided to customers with installed ~~systems.~~systems, e-governance solutions to governmental agencies in the health and education sectors,

as well as remittance and related services, including travel, from our new financial exchange. International revenue accounted for ~~34.0%~~53.9% and ~~25.7%~~34.0% of the Company’s total revenue for the three months ended March 31, ~~2017~~2018 and ~~2016,~~2017, respectively.

Ebix’s revenue streams come from four product/service channels. Presented in the table below is the breakout of our revenues for each of those product/service channels for the three and three month periods ended March 31, ~~2017~~2018 and ~~2016.~~

2017.


	Three Months Ended				Three Months Ended
	March 31,				March 31,
(dollar amounts in thousands)	2017		2016
(In thousands)					2018		2017
Exchanges	$	52,614	$	50,086	$	81,858	$	52,614
Broker Systems	3,788		3,212		3,610		3,788
Risk Compliance Solutions (“RCS”)	21,852		16,751
RCS					22,267		21,852
Carrier Systems	849		1,017		495		849
Totals	$	79,103	$	71,066	$	108,230	$	79,103

The Company is continuing to evaluate the classification of the 2017 acquisitions that collectively make up the EbixCash Financial Exchanges, refer to Part I, Item I Business in our Form 10-K for the year ended December 31, 2017. Currently they are reported under Exchange channel, but is subject to change based on the conclusions of our evaluations.

During the three months ended March 31, ~~2017~~2018 our total operating revenues increased ~~$8.0~~$29.1 million or ~~11%~~37%, to ~~$79.1~~$108.2 million as compared to ~~$71.1~~$79.1 million during the first quarter of ~~2016. Revenues~~2017. The year-over-year revenues primarily increased ~~primarily due~~as a result

of the Company's acquisitions of Via, YouFirst and ItzCash.

During the three months ended March 31, 2018 the Company's reported total operating revenues increased by $29.1 million or 37% to $108.2 million as compared to $79.1 million during the ~~signing and initiation of new customer contracts~~same period in the exchange and RCS channel areas, the EHAE joint venture and the new e-governance contracts in India. Finally, in the RCS division the company benefited from the acquisition of both Wdev and Hope, in November 2016.2017.

With respect to business acquisitions completed during the years ~~2017~~2018 and ~~2016~~2017 on a pro forma basis, as disclosed in the ~~table in Note 3 "Business Combinations" pertaining to~~above pro forma financial information ~~to the enclosed Condensed Consolidated Financial Statements,~~table, combined revenues ~~increased 3%~~decreased 2.7% for the three months ending March 31, ~~2017, respectively,~~2018 versus the same ~~period~~periods in ~~2016, whereas correspondingly, the reported revenue for the three months ended March 31,~~2017. The 2018 and 2017 ~~increased by $8.0 million or 11.3% from the reported revenue during the same period in 2016. The 2017 and 2016~~ pro forma financial information assumes that all business acquisitions made during this period were made on January 1, ~~2016,~~2017, whereas the Company's reported financial statements for ~~Q1 2017 and Q1 2016~~three months ended March 31, 2018 only includes the revenues from these businesses since the effective date that they were acquired or consolidated by Ebix, being ~~July 2016~~April 2017 for ~~the EbixHealth JV,~~Itzcash, June 2017 for beBetter, September 2017 for YouFirst, October 2017 for WallStreet, November ~~2016~~2017 for ~~Wdev,~~Paul Merchants, November 2017 for Via, and ~~November 2016~~February 2018 for ~~Hope. The 2016 pro forma financial information includes a full three months of results for Wdev, Hope, and the EbixHealth JV as if they had been acquired or consolidated on January 1, 2016.~~Transcorp.

The above referenced pro forma information and the relative comparative change in pro forma and reported revenues are based on the following premises:

~~2017~~•2018 and ~~2016~~2017 pro forma revenue contains actual revenue of the acquired entities before acquisition date, as reported by the sellers, as well as actual revenue of the acquired entities after acquisition, whereas the reported growth in revenues of the acquired entities after acquisition date are only reflected for the period after their acquisition.

•Revenue billed to existing clients from the cross selling of acquired products has been assigned to the acquired section of our business.

•Any existing products sold to new customers obtained through a newly acquired customer base are assigned to the acquired section of our business.

•Pro formas do not include post acquisition revenue reductions as a result of discontinuation of any product lines and/or customer projects by Ebix in line with the ~~Company~~Company's initiatives to maximize profitability.

Cost of Services Provided

Costs of services provided, which includes costs associated with maintenance, customer support, call center, consulting, implementation and training services, increased ~~$5.6~~$14.4 million or ~~28%~~57%, to $39.6 million in the first quarter of 2018 as compared to $25.2 million in the first quarter of ~~2017 as compared to $19.6 million in the first quarter of 2016.~~2017. This increase is primarily due to costs associated with ~~fully consolidating~~ the ~~EbixHealth JV, Wdev, Hope,~~business acquisitions of ItzCash,Via, YouFirst, WallStreet and ~~increased costs associated with supporting the increased revenue streams from new e-governance service contracts executed within the Ebix Vayam Limited JV.~~Paul Merchants offset by reduced U.S. consulting salary costs.

Product Development Expenses

The Company’s product development efforts are focused on the development of new processing technologies, software, systems and related services for use by healthcare professionals, consumers, insurance carriers, brokers and agents, and the development of new data exchanges for use in the domestic and international insurance markets. Product development expenses ~~increased $285 thousand or 4%,~~remained flat at $8.4 million during the first quarter of 2018 as compared to $8.4 million during the first quarter of 2017 as compared to $8.1 million during the first quarter of 2016. This increase is attributable to additional personnel costs for our growing employee base in our continually expanding product development facilities in India.

2017.

Sales and Marketing Expenses

Sales and marketing expenses ~~increased $4~~decreased $339 thousand or 0%8%, to ~~$4.34~~$4.0 million in the first quarter of 2018 as compared to $4.3 million in the first quarter of 2017 ~~as compared~~primarily due to ~~$4.33 million~~a decrease in ~~the first quarter of 2016.~~expenses relating to commissions.

General and Administrative Expenses

Reported general and administrative expenses increased ~~$1.1~~$6.8 million or ~~10%~~54% to ~~$12.68 million for the first quarter of 2017 as compared to $11.6~~$19.5 million in the first quarter of ~~2016~~2018 as compared to $12.7 million in the first quarter of 2017 primarily due to costs associated with ~~fully consolidating~~ the ~~EbixHealth~~

~~JV, Wdev~~business acquisitions of ItzCash,Via, YouFirst, WallStreet and ~~IHAC, Inc., d.b.a Hope Health ("Hope).~~Paul Merchants, a $1.1 million increase in professional fees, a $948 thousand purchase accounting adjustment in 2017, and a $638 thousand increase in bad debt expense.

Amortization and Depreciation Expenses

Amortization and depreciation expenses ~~increased $135~~decreased $48 thousand or 5%2% to $2.81 million in the first quarter of 2018 as compared to $2.86 million in the first quarter of 2017 as compared to $2.72 million in the first quarter of 2016, due primarily to additional depreciation expense being recognized with our acquisitions of Wdev, EbixHealth JV, and our expanding product development facilities in India.2017.

Interest Income

Interest income ~~increased $631~~decreased $653 thousand or ~~441%~~84% to $121 thousand in the first quarter of 2018 as compared to $774 thousand in the first quarter of 2017 primarily due to interest now recorded as ~~compared to $143 thousand~~revenue in India and a reduction in the ~~first quarter of 2016, due to a 85% increase in~~ average cash balances ~~held during Q1 of 2017 versus Q1 of 2016 which increased to $117.0 million from $63.1 million.~~in interest bearing accounts.

Interest Expense

Interest expense increased ~~$1.2~~$2.4 million or ~~94%~~96%, to $4.8 million in the first quarter of 2018 as compared to $2.5 million in the first quarter of ~~2017 as compared to $1.3 million in the first quarter of 2016.~~2017. Interest expense increased primarily due to the increase in the average outstanding balance on our commercial banking credit facilities, which increased ~~33%~~44% to $402.4 million during Q1 2018 from $278.9 million during Q1 ~~2017 from $209.8 million during Q1~~ of ~~2016,~~2017, as well as an increase in the underlying average interest rate which increased to ~~3.06%~~4.3% for ~~2017~~Q1 2018 versus ~~2.44%~~3.1% for ~~2016.~~Q1 2017.

Foreign Currency Exchange Gain (Loss)

Net foreign currency exchange ~~gains~~losses for the three months ended March 31, ~~2017~~2018 in the amount of ~~$3.5 million~~$641 thousand consists of ~~$2.6 million~~$222 thousand of ~~gains incurred~~losses realized upon the settlement of receivables or payables and ~~remeasurement~~re-measurement of cash balances denominated in currencies other than the functional currency of the respective operating division recording the instrument, and ~~$860~~$419 thousand of unrealized ~~gains~~losses pertaining to the ~~remeasurement~~re-measurement of outstanding receivables or payables denominated in currencies other than the functional currency of the respective operating division recording the instrument.

Income Taxes

The Company recorded income tax expense of ~~$869 thousand (3.2%~~$2.13 million (7.44%) during the three months ended March 31, ~~2017, respectively,~~2018 , which included discrete items for additions to the reserve for uncertain tax positions. The income tax expense exclusive of discrete items for the three months ended March 31, ~~2017, respectively,~~2018 is ~~$351 thousand (1.3%~~$2.10 million (7.33%). Our tax expense and effective tax rate ~~decreased~~increased year over year, exclusive of discrete charges, due to ~~favorable changes in~~a new minimum tax on global intangible low-taxed income (“GILTI”) earned by foreign subsidiaries as part of the ~~proportion of our taxable income in certain foreign jurisdictions relative to total pre-tax income.~~Tax Act. The Company expects its full year tax rate before discrete items to be approximately ~~1.26%~~7.35%.

On December 22, 2017, the U.S. enacted the Tax Act, which implemented a number of changes that took effect on January 1, 2018, including but not limited to, a new minimum tax on GILTI earned by foreign subsidiaries. The ~~Company’s~~Company estimated the impact of GILTI on the expected annual effective income tax rate ~~reflects~~and recorded a provisional tax expense. Any adjustment of the ~~benefits~~Company’s provisional tax expense will be reflected as a change in estimate in its results in the period in which the change in estimate is made in accordance with Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of ~~having significant operations outside~~ the ~~United States,~~Tax Cuts and Jobs Act, which ~~are generally taxed at rates lower than the US statutory rate of 35% and where~~is also included in ASU 2018-05, Income Taxes (Topic 740), Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 issued March 2018. In addition, the Company ~~enjoys a~~continues to gather information to compute the

amount of the Transition Tax under the Tax Act and expects to finalize its calculation prior to filing its U.S. federal tax holiday in India. During 2015, the Company secured an additional tax holiday in India until the year 2020 to support certain portions of its expanding operations there. The Company also had income during the quarter ended March 31, 2017 in Singapore, the United Kingdom, Dubai, and Sweden, where the statutory tax rates are lower than the US rate of 35%.return, which is due October 15, 2018.

Liquidity and Capital Resources

The Company's ability to generate significant cash flows from ongoing operating activities is one of ~~it's~~its fundamental financial strengths. Our principal sources of liquidity are the cash flows provided by the Company's operating activities, the Company's commercial banking credit facility, and cash and cash equivalents on hand. Due to the effect of temporary or timing differences resulting from the differing treatment of items for tax and accounting purposes (including the treatment of net operating loss ~~carryforwards~~carry-forwards and minimum alternative tax obligations in the U.S. ~~and~~, Great Britain, and India), future cash outlays for income taxes are expected to exceed income tax expense. We intend to utilize cash flows generated by our operations, in combination

with our commercial bank credit facility, and the possible issuance of additional equity or debt securities, to fund capital expenditures and organic growth initiatives, to make strategic and accretive business acquisitions in the insurance services sector, and to re-purchase shares of our common stock as market conditions warrant.

We believe that anticipated cash flows provided by our operating activities, together with current cash and cash equivalent balances, access to our credit facilities, and access to the capital markets, if required and available, will be sufficient to meet our projected cash requirements for the foreseeable future, although any projections of future cash needs, cash flows, and the condition of the capital markets in general, as to the availability of debt and equity financing, are subject to substantial uncertainty.

Our cash and cash equivalents were ~~$120.2~~$111.9 million and ~~$114.1~~$63.9 million at March 31, ~~2017~~2018 and December 31, ~~2016,~~2017, respectively. The ~~$11.2~~$4.0 million of restricted cash on the condensed consolidated balance sheet as of March 31, 2018 consists of the ItzCash acquisition $4.0 million of the possible future contingent earn-out payments being held in escrow accounts for the twelve month period following the effective date of the acquisition to ensure that the acquired business achieves the minimum specified annual gross revenue threshold, which if not achieved will result in said funds being returned to Ebix. The $8.6 million of restricted fiduciary funds is ~~partly~~ associated with the EbixHealth JV and pertains to ~~$8.3 million of~~ un-remitted insurance premiums and claim funds established for the benefit of various carriers which are held in a fiduciary capacity until disbursed. Additionally, as part of the Wdev acquisition $2.9 million of the upfront cash consideration is being held in an escrow account for the thirty-eight month period following the effective date of the acquisition to ensure that the acquired business achieves the minimum specified annual net revenue threshold, which if not achieved will result in said funds being returned to Ebix.

The free flow of cash from certain countries where we hold significant cash balances may be subject to repatriation tax effects and other restrictions. Specifically the repatriation of earnings from some of our foreign subsidiaries could result in the application of withholding taxes at that foreign source as well as a tax at the U.S. parent level upon receipt of repatriated amounts. The approximate cash, cash equivalents, and short-term investments balances held in our domestic U.S. operations and each of our foreign subsidiaries as of May ~~8, 2017~~7, 2018 are presented in the table below (figures denominated in thousands):



~~Country/Region~~		~~Cash and ST investments~~
~~United States~~		~~11,475~~
~~Canada~~		~~4,428~~
~~Latin America~~		~~4,223~~
~~Australia~~		~~9,312~~
~~Singapore~~		~~31,781~~
~~New Zealand~~		~~3,059~~
~~India~~		~~61,400~~
~~Europe~~		~~2,896~~
~~Mauritius~~		~~145~~
~~Sweden~~		6
~~Total~~		~~128,725~~



Country/Region	Cash and ST investments
United States	$	16,635
Canada	5,386
Latin America	2,446
Australia	6,043
Singapore	2,075
New Zealand	968
India	56,787
Europe	3,857
Mauritius	257
Dubai	145
Sweden	—
Total	$	94,599

Our current ratio increased to ~~3.14~~1.83 at March 31, ~~2017 , an increase~~2018 from ~~2.34~~1.72 at December 31, ~~2016~~2017 and accordingly our working capital position increased to ~~$148.0~~$132.2 million at March 31, ~~2017~~2018 from ~~$120.2~~$106.0 million at the end of ~~2016.~~2017. Our short-term liquidity has ~~improved~~primarily increased due to increased cash and cash ~~equivalent balances on hand, increased outstanding trade accounts receivables, additional prepaid expense assets, combined with a reduction accounts payable and accrued liabilities,~~equivalents, partially offset by a decrease ~~to the restricted cash balance.~~in short-term investments and increased deferred revenues. The Company's days sales outstanding in accounts receivable ("DSO") was 7899 days at March 31, ~~2017~~2018 up 9 7

days from 6992 days at December 31, ~~2016.~~2017. The increase is primarily due to contracts in Brazil, the US and India that have longer payment terms.

We believe that Ebix's ability to generate sustainable and robust cash flows from operations will enable the Company to continue to fund its current liabilities from current assets including available cash balances for the foreseeable future.

Business Combinations

The Company seeks to execute accretive business acquisitions in combination with organic growth initiatives as part of its comprehensive business growth and expansion strategy. The Company looks to acquire businesses that are complementary to Ebix's existing products and services.

During the three months ended March 31, 2018, the Company completed one business acquisitions, as follows:

Effective February 1, 2018 Ebix acquired the MTSS Business of Transcorp International Limited (BSE:TRANSCOR.BO), for upfront cash consideration in the amount of $7.25 million, of which $6.55 million was funded with cash and $700 thousand assumed in liabilities. Ebix is consolidating this recent acquisition into Ebix's Financial Exchange operations which will bring synergies and reduce certain redundancies to the combined operation. The valuation and purchase price allocation for the Transcorp acquisition remains preliminary and will be finalized as soon as practicable but in no event longer than one year from the effective date of this transaction.

During the twelve months ended December 31, 2017, the Company ~~did not have any business acquisitions.~~

~~During the year ended December 31, 2016, the Company~~ completed ~~three~~six business acquisitions, as follows:

Effective November 1, ~~2016~~2017 Ebix acquired ~~Wdev,~~Via, a ~~Brazilian company that provides IT services~~recognized leader in the travel space in India and ~~software development for the Latin American insurance industry.~~an Omni-channel online travel and assisted e-commerce exchange. Ebix acquired ~~Wdev~~Via for upfront cash consideration in the amount $78.8 million plus possible future contingent payments of ~~$10.5~~up to $2.3 million based on any potential claims made by tax authorities over the subsequent twelve month period following the effective date of the acquisition and $2.0 million based on the receipt of refunds pertaining to certain advance tax payments and withholding taxes, both of which are included in Other current liabilities in the Company's Consolidated Balance Sheet. The valuation and purchase price allocation for the Via acquisition remains preliminary and will be finalized as soon as practicable but in no event longer than one year from the effective date of this transaction.

On August 18 2017 Ebix entered into an agreement to acquire MTSS Business of YouFirst Money Express Private Limited ("YouFirst") for upfront cash consideration in the amount $10.2 million. The acquisition, effective September 1, 2017, was funded in October following the securing of requisite approvals for the closing. The valuation and purchase price allocation for the YouFirst acquisition remains preliminary and will be finalized as soon as practicable but in no event longer than one year from the effective date of this transaction.

thirty-six month period following the effective date of the acquisition. ~~$2.9~~$4.0 million of the ~~upfront cash consideration~~possible future contingent earn-out payments is being held in an escrow ~~account~~accounts for the ~~thirty-eight~~twelve month period following the effective date of the acquisition to ensure that the acquired business achieves the minimum specified annual ~~net~~gross revenue threshold, which if not achieved will result in said funds being returned to Ebix. The Company has determined that the fair value of the contingent earn-out consideration is $34.0 million as of March 31, 2018. The valuation and purchase price allocation for the ~~Wdev~~ItzCash acquisition remains preliminary and will be finalized as soon as practicable but in no event longer than one ~~year.~~

~~Effective November 1, 2016 Ebix acquired~~year from the ~~assets~~effective date of Hope, a Michigan corporation and publisher of health and wellness continuing education products. Ebix acquired the assets and intellectual property of Hope for $1.72 million. The valuation and purchase price allocation for the Hope acquisition remains preliminary and will be finalized prior to June 30, 2017.this transaction.

Effective July 1, 2016 Ebix and IHC jointly executed a Call Notice agreement, whereby Ebix purchased additional common units in the EbixHealth JV from IHC constituting eleven percent (11%) of the EbixHealth JV for $2.0 million cash which resulted in Ebix holding an aggregate fifty-one percent (51%) controlling equity interest in the EbixHealth JV. Commensurate with additional equity stake in the joint venture a contemporaneous valuation of the business was completed. In accordance with the technical accounting guidance pertaining to step acquisitions the Company recorded goodwill in the amount of $21.8 million, a non-controlling interest in the amount of $11.2 million, and recognized a $1.16 million gain on its previously carried 40% equity interest in the EbixHealth JV. This recognized gain is reflected as a component of other non-operating income in the accompanying Condensed Consolidated Statement of Income. The valuation and purchase price allocation for the EbixHealth JV acquisition remains preliminary and will be finalized prior to June 30, 2017. Previously, effective September 1, 2015 Ebix and Independence Holdings Corporation ("IHC") formed a joint venture named Ebix Health Exchange Holdings, LLC ("EbixHealth JV"). Ebix paid $6.0 million and contributed a license to use certain CurePet software and systems valued by the EbixHealth JV at $2.0 million, for its initial 40% membership interest in the EbixHealth JV.

A significant component of the purchase price consideration for many of the Company's business acquisitions is a potential subsequent cash ~~earnout~~earn-out payment based on reaching certain specified future revenue targets. The terms for the contingent ~~earn out~~earn-out payments in most of the Company's business acquisitions typically address the GAAP recognizable revenues achieved by the acquired entity over a one, two, and/or three year period subsequent to the effective date of their acquisition by Ebix. These terms typically establish a minimum threshold revenue target with achievement of revenues recognized over that target being awarded in the form of a specified cash earn out payment. The Company applies these terms in its calculation and determination of the fair value of contingent earn out liabilities for purchased businesses as part of the related valuation and purchase price allocation exercise for the corresponding acquired assets and liabilities. The Company recognizes these potential obligations as contingent ~~liabilities. These~~liabilities and are reported as such on its Condensed Consolidated Balance Sheets. As discussed in more detail in Note 1, to the Notes to Condensed Consolidated Financial Statements, these contingent consideration liabilities are recorded at fair value on the acquisition date and are re-measured quarterly based on the ~~then-assessed~~then assessed fair value and adjusted if necessary. As of March 31, ~~2017,~~2018, the total of these contingent liabilities was ~~$8.75~~$36.5 million, of which ~~$6.81~~$32.5 million is reported in long-term liabilities, and ~~$1.94~~$4.0 million is included in current liabilities in the Company's Condensed Consolidated Balance Sheet. As of December 31, ~~2016~~2017 the total of these contingent liabilities was ~~$8.51~~$37.1 million, of which ~~$6.59~~$33.1 million was reported in long-term liabilities, and ~~$1.92~~$4.0 million was included in current liabilities in the Company's Condensed Consolidated Balance Sheet. ~~During 2016 the cited contingent earn out liabilities were adjusted because of changes to anticipated future revenues from these acquired businesses.~~

Operating Activities

Net cash provided by our operating activities was $25.5 million for the three months ended March 31, 2018. The primary components of the cash provided by our operating activities during the three month period consisted of net income of $26.2 million, net of $419 thousand of unrealized foreign currency exchange gains, $2.8 million of depreciation and amortization, $248 thousand of net income attributable to a non-controlling interest, $753 thousand of non-cash share-based compensation, and $525 thousand of amortization of capitalized software development costs. Partially offsetting this net cash inflow was $(5.5) million of working capital requirements primarily due to increased outstanding trade accounts receivable and other assets and a decrease in deferred revenues. During the three months ended March 31, 2018 the Company made $6.8 million of tax payments including $2.5 million of minimum alternative tax payments in India, which is a component of net deferred tax assets on the Company's Condensed Consolidated Balance Sheets.

Net cash provided by our operating activities was $15.7 million for the three months ended March 31, 2017. The primary components of the cash provided by our operating activities during the three month period consisted of net income of $26.4 million, net of $(860) thousand of unrealized foreign currency exchange gains, $2.9 million of depreciation and amortization, $196 thousand of net income attributable to a non-controlling interest, $686 thousand of non-cash share-based compensation, and $410 thousand of amortization of capitalized software development costs. Partially offsetting this net cash inflow was $(13.1) million of working capital requirements primarily due to increased outstanding trade accounts receivable combined with a reduction in accounts payable and accrued operating and payroll expenses. During the three months ended March 31, 2017 the Company made $6.7 million of tax payments including $4.9 million of minimum alternative tax payments in India, which is a component of net deferred tax assets on the Company's Condensed Consolidated Balance Sheets.

Investing Activities

Net cash provided by ~~our operating~~investing activities ~~was $10.5 million for~~during the three months ended March 31, ~~2016. The primary components of the cash used in operations during the three month period~~2018 was $2.5 million, and consisted of $5.0 million received from Paul Merchants for a 10% equity interest in Ebix’s combined international remittance business in India, $5.2 million for the net ~~income~~maturities of ~~$22.2~~marketable securities (specifically bank certificates of deposit). Partially offsetting these inflows were $6.6 million ~~net~~used for the acquisition of ~~$(48)~~Transcorp, $531 thousand for the expansion of ~~unrealized foreign currency exchange gains, $2.7 million~~our product development facilities in India and the continued build out of ~~depreciation~~our global corporate headquarters campus in Johns Creek, Georgia, and ~~amortization, $192~~$622 thousand ~~of net~~

~~income attributable to a noncontrolling interest, $647 thousand of non-cash share-based compensation, and $326 thousand of amortization of capitalized~~for software development costs. Partially offsetting this net cash inflow was $(15.0) million of working capital requirements primarily associated with increased outstanding trade accounts receivable combined with a reduction in accounts payable and accrued expenses. During the three months ended March 31, 2016 the Company made $7.0 million of tax payments including $6.0 million of minimum alternative tax payments in India, which is a component of net deferred tax assets on the Company's Condensed Consolidated Balance Sheets.costs that were capitalized.

~~Investing Activities~~

Net cash used for investing activities during the three months ended March 31, 2017 was $4.2 million, of which $1.3

million was used for the expansion of our product development facilities in India, $1.4 million was used for the continued build

out of our global corporate headquarters campus in Johns Creek, Georgia, $514 thousand was used for software development costs that were capitalized, and $1.0 million was used for the purchase of marketable securities (specifically bank certificates of deposit).

~~Net cash used for investing activities during~~

Financing Activities

During the three months ended March 31, ~~2016~~2018 net cash provided by financing activities was ~~$1.8~~$21.8 million which consisted of ~~which $1.0~~$124.3 million provided by the refinancing and borrowing from the amended and expanded syndicated credit facility with Regions Bank, $20.0 million provided by the Company's revolving credit facility with Regions, $745 thousand provided by the EbixCash overdraft facility in India. Partially offsetting this cash inflow were $120.8 million used as part of the refinancing and borrowing from the amended and expanded syndicated credit facility with Regions Bank and $2.4 million was used ~~for the continued build out of~~to pay quarterly dividends to our global corporate headquarters campus in Johns Creek, Georgia and our expanding product development facilities in India, and $596 thousand was used for the purchase of marketable securities (specifically bank certificates of deposit).common stockholder.

~~Financing Activities~~

During the three months ended March 31, 2017 net cash used by financing activities was $6.2 million which consisted of $40.5 million used to repurchase shares of our common stock, $2.4 million was used to pay quarterly dividends to our common stockholders, and $3.13 million was used to make the scheduled payments against the existing term loan with Regions. Partially offsetting these cash outflows was $40.0 million provided by the Company's revolving credit facility with Regions.

Commercial Bank Financing Facility

~~During~~

On February 21, 2018, Ebix, Inc. and certain of its subsidiaries entered into the ~~three months ended March 31, 2016 net cash used~~Sixth Amendment (the “Sixth Amendment”) to the Regions Secured Credit Facility, dated August 5, 2014, among the Company, Regions Bank as Administrative and Collateral Agent ("Regions") and certain other lenders party thereto (as amended, the "Credit Agreement"). The Sixth Amendment amends the Credit Agreement by ~~financing activities~~increasing its existing credit facility from $450 million to $650 million, to assist in funding its growth. The increase in the bank line was ~~$10.0~~the result of many members of the existing bank group expanding their share of the credit facility and the addition of BBVA Compass and Bank West to the Banking Syndicate, which diversifies Ebix’s lending group under the credit facility to ten participants.The syndicated bank group now comprises ten leading financial institutions that include Regions Bank, PNC Bank, BMO Harris Bank, BBVA Compass, Fifth Third Bank, KeyBank, Bank West, Silicon Valley Bank, Cadence Bank and Trustmark National Bank. Regions Bank continued to lead the banking group while serving as the administrative and collateral agent. PNC Bank and BMO Harris Bank were added as co syndication agents, BBVA Compass and Fifth Third Bank as co documentation agent, while Regions Capital Markets, PNC Capital Markets and BMO Harris Bank acted as joint lead arrangers and joint bookrunners. The new credit facility has the following key components; A five-year term loan for $250 million, ~~which consisted of $22.3~~with initial repayments starting June 30, 2018 due in the amount $3.13 million ~~used to repurchase shares of our common stock, $2.7 million was used to pay~~for the first eight quarters and increasing thereafter and a quarterly dividend to our common stockholders, and $12 thousand was used to make principal payments on long-term debt and capital lease obligations. Partially offsetting these financing cash outflows was $15.0 million provided by the Company'sfive-year revolving credit facility ~~with Regions.~~

~~Commercial Bank Financing Facility~~for $400 million. The new credit facility, also, allows for up to $150 million of incremental facilities. The Credit Agreement carries a leverage-based LIBOR related interest rate, which currently stands at approximately 3.88%.

On June 17, 2016, the Company and certain of its subsidiaries entered into the Second Amendment (the “Second Amendment”) to the ~~Regions Secured~~ Credit ~~Facility (as defined below), dated August 5, 2014, among the Company, Regions,~~Agreement, Regions Capital Markets, PNC Capital Markets, LLC, and TD Securities (USA) as joint Lead Arrangers for the syndicate of ~~lenders.~~lenders (the “Regions Secured Credit Facility”). The Second Amendment increases the total credit facility to $400 million from the prior amount of $240 million, and expands the syndicated bank group to eleven participants by adding seven new participants which include PNC Bank, National Association BMO Harris Bank N.A., Key Bank National Association, HSBC Bank National, Cadence Bank, the Toronto-Dominion Bank (New York Branch), and Trustmark National Bank. The Credit Agreement ~~(as defined below)~~ now consists of a ~~5-year~~five-year revolving credit component in the amount of $275 million, and a five-year term loan component in the amount of $125 million, with repayments due in the amount ~~$3.125~~$3.13 million due each quarter, starting September 30, ~~2016.~~2016 . The Credit Agreement also contains an accordion feature, which if exercised and approved by all credit parties, would expand the total borrowing capacity under the syndicated credit facility to $500 million. ~~The credit facility carries a leverage-based LIBOR related interest rate, which currently stands at approximately 3.06%.~~

As of March 31, ~~2017~~2018 the Company's consolidated balance sheet includes ~~$3.0~~$5.7 million of remaining deferred financing costs in connection with this credit facility, which are being amortized as a component of interest expense over the five-year term of the financing agreement. In regards to these deferred financing costs, ~~$2.4~~$3.5 million pertains to the revolving line of credit component of the Credit Agreement, and ~~$571 thousand~~$2.2 million pertains to the term loan component of the Credit Agreement of which ~~$136~~$449 thousand is netted against the current portion and ~~$435 thousand~~$1.7 million is netted against the long-term portions of the term loan as reported on the Condensed Consolidated Balance.

At March 31, ~~2017,~~2018, the outstanding balance on the revolving line of credit under the Credit Agreement was ~~$194.0~~$173.7 million and the facility carried an interest rate of ~~3.06%~~3.88%. During the three months ended March 31, ~~2017, $40.0~~2018, $20.0 million of draws were made off of the revolving credit facility. The revolving line of credit balance is included in the long-term liabilities section of the Condensed Consolidated Balance Sheets. During the three months ~~period~~ ended March 31, ~~2017,~~2018, the average and maximum

outstanding balances of the revolving line of credit component of the credit facility were ~~$160.2~~$224.2 million and ~~$194.0~~$274.5 million, respectively.

At March 31, ~~2017,~~2018, the outstanding balance on the term loan was ~~$115.6~~$250.0 million of which $12.5 million is due within the next twelve ~~months.~~months, with no payments having been made during the three months ended March 31, 2018. This term loan also carried an interest rate of ~~3.06%~~3.88%. The current and long-term portions of the term loan are included in the respective current and long-term sections of the Condensed Consolidated Balance Sheets, the amounts of which were $12.5 million and ~~$103.1~~$237.5 million respectively at March 31, ~~2017.~~2018.

Contractual Obligations

For a presentation regarding material changes outside the ordinary course of business to the Company's contractual obligations please refer to Notes 3, 4 and 5 of the Notes to Condensed Consolidated Financial Statements.

Off-Balance Sheet Arrangements

We do not engage in off balance sheet financing arrangements.

Recent Accounting Pronouncements

For information about new accounting pronouncements and the potential impact on our Consolidated Financial Statements, see Note 1 of the condensed notes to the Condensed Consolidated Financial Statements in this Form 10-Q and Note 1 of the notes to consolidated financial statements in our ~~2016~~2017 Form 10-K.

Application of Critical Accounting Policies

The preparation of financial statements in conformity GAAP, as promulgated in the United States, requires our management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and related disclosures in our Condensed Consolidated Financial Statements and accompanying notes. We believe the most complex and sensitive judgments, because of their significance to the Condensed Consolidated Financial Statements, result primarily from the need to make estimates and assumptions about the effects of matters that are inherently uncertain. The following accounting policies involve the use of “critical accounting estimates” because they are particularly dependent on estimates and assumptions made by management about matters that are uncertain at the time the accounting estimates are made. In addition, while we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used in the current period, and changes in the accounting estimates that we used are reasonably likely to occur from period to period both of which may have a material impact on our financial condition and results of operations. For additional information about these policies, see Note 1 of the Condensed Notes to the Condensed Consolidated Financial Statements in this Form 10-Q. Although we believe that our estimates, assumptions and judgments are reasonable, they are limited based upon information presently available. Actual results may differ significantly from these estimates under different assumptions, judgments or conditions.

Revenue Recognition

The Company derives its revenues primarily from subscription and transaction fees pertaining to services delivered over our exchanges or from our ~~ASP~~application service provider ("ASP") platforms, fees for ~~business process outsourcing~~risk compliance solution services, and fees for software development projects including associated fees for consulting, implementation, training, and project management provided to customers with installed ~~systems.~~systems and applications. Sales and value-added taxes are not included in revenues, but rather are recorded as a liability until the taxes assessed are remitted to the respective taxing authorities.

~~In accordance with~~Under Topic 606, revenue is recognized when control of the ~~FASB and SEC accounting guidance on~~promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.

We determine revenue recognition through the ~~Company considers revenue earned and realizable when: (a) persuasive evidence~~following steps:

identification of the ~~sales arrangement exists, provided that the arrangement fee is fixed~~contract, or ~~determinable, (b) delivery or performance has occurred, (c) customer acceptance has been received, if contractually required, and (d) collectability~~contracts, with a customer;

determination of the ~~relevant generally accepted accounting principles related to all transactions involving~~transaction price;

recognition of revenue when, or as, we satisfy a performance obligation.

For contracts that contain multiple deliverables, we analyze the revenue arrangements in accordance with the relevant technical accounting guidance, which provides criteria governing how to determine whether goods or services that are delivered separately in a bundled sales arrangement should be considered as separate ~~units of accounting~~performance obligations for the purpose of revenue recognition. ~~Generally these~~These types of arrangements include ~~deliverables~~obligations pertaining to software licenses, system set-up, and professional services associated with product customization or modification. Delivery of the various contractual ~~elements~~obligations typically occurs over periods of less than eighteen months. These arrangements generally do not have refund provisions or have very limited refund terms.

Allowance for Doubtful Accounts Receivable

Management specifically analyzes accounts receivable and historical bad debts, write-offs, customer concentrations, customer credit-worthiness, current economic trends and changes in our customer payment terms when evaluating the adequacy of the allowance for doubtful accounts.

Valuation of Goodwill and Other Indefinite-Lived Intangible Assets

Goodwill represents the cost in excess of the fair value of the net assets of acquired businesses. Indefinite-lived intangible assets represent the fair value of acquired contractual customer relationships for which future cash flows are expected to continue indefinitely. In accordance with the relevant FASB accounting guidance, goodwill and indefinite-lived intangible assets are not amortized but are tested for impairment at the reporting unit level on an annual basis or on an interim basis if an event occurs or circumstances change that would likely have reduced the fair value of a reporting unit below its carrying value. Potential impairment indicators include a significant change in the business climate, legal factors, operating performance indicators, competition, and the sale or disposition of a significant portion of the business. The impairment evaluation process first involves an assessment of certain qualitative factors to determine whether the existence of events or circumstances would indicate that it is more likely than not that the fair value of any of our reporting units was less than its carrying amount. If, after assessing the totality of events or circumstances, we were to determine that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then we would not perform the two-step quantitative impairment testing described further below.

The aforementioned two-step quantitative testing process involves comparing the reporting unit carrying values to their respective fair values. We determine the fair value of our reporting units by applying the discounted cash flow method using the present value of future estimated net cash flows. If the fair value of a reporting unit exceeds its carrying value, then no further testing is required. However, if a reporting unit's fair value were to be less than its carrying value, we would then determine the amount of the impairment charge, if any, which would be the amount that the carrying value of the reporting unit's goodwill exceeded its implied value. Projections of cash flows are based on our views of growth rates, operating costs, anticipated future economic conditions and the appropriate discount rates relative to risk and estimates of residual values. We believe that our estimates are consistent with assumptions that marketplace participants would use in their estimates of fair value. The use of different estimates or assumptions for our projected discounted cash flows (e.g., growth rates, future economic conditions, discount rates and estimates of terminal values) when determining the fair value of our reporting units could result in different values and may result in a goodwill impairment charge. We perform our annual goodwill impairment evaluation and testing as of September 30th of each year. This evaluation is done during the fourth quarter each year. During the year ended December 31, ~~2016~~2017 we had no impairment of our reporting unit goodwill balances.

Valuation of Contingent Liabilities related to Earn-Out Obligations from Business Acquisitions

A significant component of the purchase price consideration for many of the Company's business acquisitions is a potential subsequent cash ~~earnout~~earn-out payment based on reaching certain specified future revenue targets. The terms for the contingent earn out payments in most of the Company's business acquisitions typically address the GAAP recognizable revenues achieved by the acquired entity over a one, two, and/or three year period subsequent to the effective date of their acquisition by Ebix. These terms typically establish a minimum threshold revenue target with achievement of revenues recognized over that target being awarded in the form of a specified cash earn out payment. The Company applies these terms in its calculation and determination of the fair value of contingent earn out liabilities for purchased businesses as part of the related valuation and purchase price allocation exercise for the corresponding acquired assets and liabilities. The Company recognizes these potential obligations as contingent liabilities and are reported as such on its Condensed Consolidated Balance Sheets. During the three months ended March 31, ~~2017~~2018 and ~~2016~~2017, these aggregate contingent accrued earn-out business acquisition consideration liabilities were reduced by zero and ~~$511 thousand,~~zero, respectively, due to ~~remeasurements as~~re-measurements based on the then assessed fair value and changes in anticipated future revenue levels. ~~These~~In the first three months ended March 31, 2018 and 2017 these reductions to the contingent accrued earn-out liabilities ~~in the first quarter of 2016~~ resulted in a corresponding reduction of ~~$511 thousand~~zero and zero, respectively to general and administrative expenses as reported on the Condensed Consolidated Statements of Income and a reduction of zero and zero, respectively to goodwill as reported onin the enclosed Condensed Consolidated Balance Sheets. As of March 31, ~~2017,~~2018, the total of these contingent liabilities was ~~$8.75~~$36.5 million.

Income Taxes

Deferred income taxes are recorded to reflect the estimated future tax effects of differences between financial statement and tax basis of assets, liabilities, operating losses, and tax credit carry forwards using the tax rates expected to be in effect when the temporary differences reverse. Valuation allowances, if any, are recorded to reduce deferred tax assets to the amount management considers more likely than not to be realized. Such valuation allowances are recorded for the portion of the deferred tax assets that are not expected to be realized based on the levels of historical taxable income and projections for future taxable income over the periods in which the temporary differences will be deductible.

The Company also applies FASB accounting guidance on accounting for uncertainty in income taxes positions. This guidance clarifies the accounting for uncertainty in income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.

Foreign Currency Matters

The functional currency for the Company's foreign subsidiaries in India, Dubai, and Singapore is the U.S. dollar because the intellectual property research and development activities provided by its Dubai and Singapore subsidiary, and the product development and information technology enabled services activities for the insurance industry provided by its India subsidiary, both in support of Ebix's operating divisions across the world, are transacted in U.S. dollars.

The functional currency of the Company's other foreign subsidiaries is the local currency of the country in which the subsidiary operates. The assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at the rates of exchange at the balance sheet dates. Income and expense accounts are translated at the average exchange rates in effect during the period. Gains and losses resulting from translation adjustments are included as a component of other comprehensive income in the accompanying Condensed Consolidated Balance Sheets. Foreign exchange transaction gains and losses that are derived from transactions denominated in a currency other than the subsidiary's functional currency are included in the determination of net income.

Item 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company is exposed to foreign currency exchange rate risk related to our foreign-based operations where certain transactions are denominated in other than our entity's functional currency and are subject to market risk with respect to fluctuations in the relative value of those currencies. ~~Most~~A majority of the ~~Company's~~Company’s operations are based in the U.S and India, furthermore the functional currencies in our main India and Singapore offices is the U.S. dollar, and accordingly, a substantial portion of our business transactions are denominated in U.S. ~~dollars; however,~~dollars. However, the Company has ~~significant and expanding~~ operations in Australia, India (specifically EbixCash), New Zealand, Great Britain, Canada, Brazil, Dubai, Singapore, Philippines, Indonesia, and ~~Europe, and~~United Arab Emirates where we conduct transactions in the local currencies of each of ~~those locations. There~~these locations.There can be no assurance that fluctuations in the value of foreign currencies will not have a material adverse effect on the Company’s business, operating results, revenues or financial condition. During the three months ended March 31, ~~2017~~2018 and ~~2016~~2017 the net change in the cumulative foreign currency translation account, which is a component of accumulated other comprehensive loss within stockholders’ equity, were unrealized ~~losses~~gains (losses) of ~~$2.5~~$4.8 million and ~~$1.7~~$2.5 million, respectively. The Company considered the historical trends in currency exchange rates and determined that it was reasonably possible that adverse changes in our respective foreign currency exchange rates of 20% could be experienced in the near term. Such an adverse change in currency exchange rates would have resulted in reduction to pre-tax income of approximately ~~$2.3~~$3.1 million and ~~$940 thousand~~$2.3 million for the three months ended March 31, ~~2017~~2018 and ~~2016,~~2017, respectively.

The Company's exposure to interest rate risk relates to its interest expense on outstanding debt obligations and to its interest income on existing cash balances. As of March 31, ~~2017~~2018 the Company had ~~$309.7~~$425.5 million of outstanding debt obligations which consisted of a ~~$115.6~~$250.0 million term loan, ~~and~~ a ~~$194.0~~$173.7 million balance on our commercial banking revolving line of ~~credit.~~credit, and a $1.8 million note due to IHC by the EbixHealth JV. The Company's revolving line of credit bears interest at the rate of LIBOR plus 2.25%, and stood at ~~3.06%~~3.88% at March 31, ~~2017.~~2018. The Company is exposed to market risk in relation to this line of credit in regards to the potential increase in interest expense arising from adverse changes in interest rates. This interest rate risk is estimated as the potential decrease in earnings resulting from a hypothetical 30 basis point increase in the LIBOR rate. Such an adverse change in the LIBOR rate would have resulted in a reduction to pre-tax income of approximately ~~$179~~$611 thousand and ~~$107~~$179 thousand for the three months ended March 31, ~~2017~~2018 and ~~2016,~~2017, respectively. The Company's average cash balances and short term investments during the three months ended March 31, ~~2017~~2018 were ~~$117.0~~$109.9 million and its existing cash balances as of March 31, ~~2017~~2018 were ~~$120.2~~$111.9 million. The Company is exposed to market risk in relation to these cash balances in regards to the potential loss of interest income arising from adverse changes in interest rates. This interest rate risk is estimated as the potential decrease in earnings resulting from a hypothetical 20 basis point interest rates earned on deposited funds. Such an adverse change in these interest rates would have resulted in a reduction to pre-tax income of approximately ~~$155~~$139 thousand and ~~$29~~$155 thousand for the three months ended March 31, ~~2017~~2018 and ~~2016,~~2017, respectively.

There were no other material changes to our market risk exposure during the three months ended March 31, ~~2017~~2018 and ~~2016~~2017. For additional information regarding our exposure to certain market risks, see “Quantitative and Qualitative Disclosures about Market Risk,” in Part II, Item 7A of our ~~2016~~2017 Form 10-K.

Item 4: CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and ~~Procedures:~~ ~~The Company's~~Procedures

We maintain a system of disclosure controls and procedures designed to provide reasonable assurance that the information required to be disclosed by the Company in reports that we file and submit under the Exchange Act is recorded, processed, summarized and reported accurately within the time periods specified in the SEC's rules and forms. Disclosure controls also are designed to reasonably assure that such information is accumulated and communicated to management, ~~evaluated, with the participation of~~including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures. Disclosure controls include components of internal control over financial reporting, which consists of control processes designated to provide reasonable assurance regarding the ~~effectiveness~~reliability of financial reporting and the ~~Company's~~preparation of financial statements in accordance with United States generally accepted accounting principles.

We monitor and evaluate on an ongoing basis our disclosure controls and procedures in order to improve their overall effectiveness. In the course of these evaluations, we modify and refine our internal processes and controls as conditions warrant.

Our management, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our “disclosure controls and procedures” (as defined in Rule 13a-15(e) promulgated under the Exchange Act) as of ~~the end of the period covered by this report.~~March 31, 2018. Based on ~~that~~this evaluation the Company’s Chief Executive Officer and Chief Financial Officer have concluded that as a result of not having completed the ~~Company's~~remediation of the material weaknesses in internal control over financial reporting identified and described in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2017, the Company’s disclosure controls and procedures were not effective as of March 31, 2018.

Remediation Plans

Management is actively remediating the ~~end~~identified material weaknesses as identified and described in Item 9A of our Annual Report on Form 10-K, and has identified the following remediation steps:

The engagement of Ernst & Young LLP to assist in the review and analysis of the ~~period covered by this report.~~Company’s interim and annual income tax provision methodology computations and financial reporting;

The strengthening of controls for income taxes in 2018 with the use of additional resources and expanded use of independent third party resources and outside legal tax counsel

Reviewing and revising internal procedures surrounding valuation accounting, including the use of independent third party resources, internal review and documentation processes.

Changes in Internal Control over Financial ~~Reporting:~~ ~~There were no~~Reporting

The above described remediation actions are changes in ~~our~~the Company’s internal control over financial reporting ~~during~~(as defined in Securities Exchange Act Rule 13a-15(f) or Rule 15d-15(f)) made in the ~~three months ended~~ ~~March 31, 2017~~,first quarter of 2018 or in the process of being made that have materially affected, or are reasonably likely to materially affect, ~~our~~the Company’s internal control over financial reporting.

Part II — OTHER INFORMATION

Item 1: LEGAL PROCEEDINGS

~~Closure of SEC Investigation~~

On February 3, 2017, the Company received a letter from the Staff of the SEC stating that the Staff has concluded the previously disclosed investigation relating to the Company and that the Staff does not intend to recommend any enforcement action by the SEC against the Company.

~~Other Legal Matters~~

Following the announcement on May 1, 2013 of the Company's execution of a merger agreement with affiliates of Goldman Sachs & Co., twelve putative class action complaints challenging the proposed merger were filed in the Delaware Court of Chancery. These complaints ~~name~~named as Defendants some combination of the Company, its directors, Goldman Sachs & Co. and affiliated entities. On June 10, 2013, the twelve complaints were consolidated by the Delaware Court of Chancery, now captioned In re Ebix, Inc. Stockholder Litigation, CA No. 8526-VCS. On June 19, 2013, the Company announced that the merger agreement had been terminated pursuant to a Termination and Settlement Agreement dated June 19, 2013. After Defendants moved to dismiss the consolidated proceeding, ~~Lead~~ Plaintiffs Desert States Employers & UFCW Union Pension Plan and Gilbert C. Spagnola (collectively, “Lead Plaintiffs”) amended their operative complaint to drop their claims against Goldman Sachs & Co. and focus their allegations on an Acquisition Bonus Agreement (“ABA”) between the Company and Robin Raina. On September 26, 2013, Defendants moved

to dismiss the Amended Consolidated Complaint. On July 24, 2014, the Court issued its Memorandum Opinion that granted in large part the Company’s Motion to Dismiss and narrowed the remaining claims. On September 15, 2014, the Court entered an Order implementing its Memorandum Opinion. On January 16, 2015, the Court entered an Order permitting Plaintiffs to file a Second Amended and Supplemented Complaint. On February 10, 2015, Defendants filed a Motion to Dismiss the Second Amended and Supplemented Complaint, which was granted in part and denied in part in a January 15, 2016 Memorandum Opinion and Order. On October 25, 2016, the Court entered an Order permitting Lead Plaintiffs to file a Verified Third Amended and Supplemented Class Action and Derivative Complaint, which made additional claims and added two directors as defendants. The Verified Third Amended and Supplemented Class Action and Derivative Complaint was then filed on October 26, 2016. On October 31. 2016, Lead Plaintiffs filed a Motion for Class Certification. On November 1, 2016, Lead Plaintiffs moved for partial summary judgment on Claims (ii), (iii), and (vi) as described below. The directors added as defendants in the Third Amended and Supplemented Class Action and Derivative Complaint moved to dismiss all Claims against them. The remaining Defendants moved to dismiss certain Claims, and filed answers to the other claims in the Verified Third Amended and Supplemented Complaint. On December 12, 2017, the Court postponed the pending hearing on the Plaintiffs’ Motion for Class Certification and the Defendants’ motions to dismiss and, instead, granted the Plaintiffs leave to file a Verified Fourth Amended and Supplemented Class Action and Derivative Complaint, which pleading was filed on January 19, 2018. The claims in the fourth amended complaint are as follows: (i) a purported class and derivative claim for breach of fiduciary duty for improperly maintaining the ABA as an unreasonable anti-takeover device; (ii) a purported class claim for breach of the fiduciary duty of disclosure to the stockholders with respect to the Company’s 2010 Proxy Statement and 2010 Stock Incentive Plan; (iii) a purported derivative claim for breach of fiduciary duty to the Company in causing incentive compensation to be awarded under the 2010 Stock Incentive Plan; (iv) a purported class and derivative claim for breach of fiduciary duty in adopting certain bylaw amendments on December 19, 2014; (v) a purported class and derivative claim seeking invalidation of the December 19, 2014 bylaw amendments under Delaware law; (vi) a purported claim for breach of fiduciary duty for not duly adopting the ABA at the July 15, 2009 Board meeting, and seeking declaratory relief invalidating the ABA; (vii) a purported claim for breach of the fiduciary duty of disclosure to the stockholders with respect to the ABA, and seeking declaratory relief invalidating the ABA; (viii) a purported claim seeking invalidation of the 2008 Stockholder Meeting, 2008 Certificate Amendment, 2008 Stock Split and subsequent corporate actions; ~~and,~~ (ix) a purported class claim for breach of fiduciary duty, and seeking declaratory relief invalidating the 2016 CEO Bonus Plan because of incomplete disclosures with respect to the ABA; and (x) for breach of fiduciary duty and declaratory judgment relating to the interpretation of the ABA. Lead Plaintiffs seek declaratory relief with respect to the ABA, the 2010 Stock Incentive Plan, the 2010 Proxy Statement, the bylaw amendments, the 2008 Stockholder Meeting, the 2008 Certificate Amendment, the 2008 Stock Split, and the 2016 CEO Bonus Plan. Lead Plaintiffs also seek compensatory damages, interest, and attorneys’ fees and ~~costs. On October 31, 2016, Lead Plaintiffs filed a Motion~~costs, all in unspecified amounts. A trial is scheduled for ~~Class Certification. On November 1, 2016, Lead Plaintiffs~~

moved for partial summary judgment on Claims (ii), (iii), and (vi) as described above. The directors added as defendants in the Third Amended and Supplemented Class Action and Derivative Complaint moved to dismiss all Claims against them. The remaining Defendants moved to dismiss Claims (v), (vi), (vii), (viii), and (ix) as described above, and have filed answers to the other claims in the Verified Third Amended and Supplemented Complaint. Briefing schedules for the pending motions have not been yet set and discovery is on-going.August 2018. The Company denies any liability and intends to defend the action vigorously.

Item 1A: RISK FACTORS

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, ~~2016,~~2017, which could materially affect the Company's business, financial condition or future results. There have not been any significant changes with respect to the risk factors described in ~~Ebix's 2016~~the Company's 2017 Annual Report on Form 10-K. The risks described in that ~~2016~~2017 Form 10-K and in this Quarterly Report on Form 10-Q are not the only risks that the Company faces. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Item 2: REPURCHASES OF EQUITY SECURITIES

The following table contains information with respect to purchases of our common stock made by or on behalf of Ebix during the three months ended March 31, ~~2017,~~2018, as part of our publicly-announced share repurchase plan:

Total Number of Shares (Units) Purchased Total Number of Shares Purchased as Part of
Publicly-Announced Plans or Programs Average Price Paid Per Share (1) Maximum Number (or
Approximate Dollar Value) of
Shares that May Yet Be
Purchased Under the Plans or Programs (2) (3) (4)
Period

As of December 31, 2016 (3) 12,257,274
12,257,274
$ —
$ 23,243,000
January 1, 2017 to January 31, 2017 126,472
126,472
$ 56.20
$ 16,136,000
February 1, 2017 to February 28, 2017 159,884
159,884
$ 56.66
$ 157,076,000
March 1, 2017 to March 31, 2017 307,692
307,692
$ 58.50
$ 139,076,000
Total 12,851,322
12,851,322
$ 139,076,000



	Total Number of Shares (Units) Purchased	Total Number of Shares Purchased as Part of Publicly-Announced Plans or Programs	Average Price Paid Per Share (1)		Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs (2)
Period	Total Number of Shares (Units) Purchased		Average Price Paid Per Share (1)

January 1, 2018 to January 31, 2018	—	—	$	—	$	133,861,000
February 1, 2018 to February 28, 2018	—	—	$	—	$	133,861,000
March 1, 2018 to March 31, 2018 (3)	3,000	3,000	$	74.22	$	131,634,520
Total	3,000	3,000			$	131,634,520


(1)	Average price paid per share for shares purchased as part of our publicly-announced plan.

(2)

Effective August 19, 2015 the Company's Board of Directors unanimously approved an additional authorized share repurchase plan of $100.0 million. The Board directed that the repurchases be funded with available cash balances and cash generated by the Company's operating activities. Under certain circumstances the aggregate amount of repurchases of the Company's equity shares may be limited by the terms and underlying financial covenants regarding the Company's commercial bank financing facility.

~~(3)~~

Effective February 6, 2017 the Company's Board of Directors unanimously approved an additional authorized share repurchase plan of $150.0 million. The Board directed that the repurchases be funded with available cash balances and cash generated by the Company's operating activities. Under certain circumstances the aggregate amount of repurchases of the Company's equity shares may be limited by the terms and underlying financial covenants regarding the Company's commercial bank financing facility.


~~(4)~~(3)	As of ~~December~~March 31, ~~2016~~2018 there ~~was 109,475~~were 30,000 shares totaling ~~$6.4~~$2.2 million of share repurchases that were not settled until ~~January 2017.~~

April 2018.

Item 3: DEFAULTS UPON SENIOR SECURITIES

None.

Item 4: MINE SAFETY DISCLOSURES

Not applicable.

Item 5: OTHER INFORMATION

~~None.~~On February 21, 2018, Ebix, Inc. and certain of its subsidiaries entered into the Sixth Amendment (the “Sixth Amendment”) to the Credit Agreement. The Sixth Amendment amends the Regions Credit Facility by increasing its existing credit facility from $450 million to$650 million, to assist in funding its growth. The increase in the bank line was the result of many members of the existing bank group expanding their share of the credit facility and the addition of BBVA Compass and Bank Of The West to the Banking Syndicate, which further diversifies Ebix’s lending group under the credit facility to ten participants.The syndicated bank group now comprises ten leading financial institutions that include Regions Bank, PNC Bank, BMO Harris Bank, BBVA Compass, Fifth Third Bank, KeyBank, Bank Of The West, Silicon Valley Bank, Cadence Bank and Trustmark National Bank. Regions Bank continued to lead the banking group while serving as the administrative and collateral agent. PNC Bank and BMO Harris Bank were added as co syndication agents, BBVA Compass and Fifth Third Bank as co documentation agent, while Regions Capital Markets, PNC Capital Markets and BMO Harris Bank acted as joint lead arrangers and joint bookrunners. The new credit facility has the following key components; A five-year term loan for $250 million, with initial repayments starting June 30, 2018 due in the amount $3.13 million for the first eight quarters and increasing thereafter and a five-year revolving credit facility for $400

million. The new credit facility, also, allows for up to $150 million of incremental facilities. The Regions Secured Credit Facility carries a leverage-based LIBOR related interest rate, which currently stands at approximately 3.88%.

On November 3, 2017 the Company and certain of its subsidiaries entered into the Fifth Amendment (the “Fifth Amendment”) to the Regions Secured Credit Facility, dated August 5, 2014, among the Company, Regions Bank as Administrative and Collateral Agent ("Regions") and certain other lenders party thereto (as amended, the "Credit Agreement") to exercise $50 million of its aggregate $100 million accordion option, increasing the total Term Loan Commitment to$175 million. $20 million of the increase was funded on November 3, 2017 and the remaining $30 million shall be disbursed upon the satisfaction of certain closing requirements set forth in the Fifth Amendment. Both such disbursements are tied to permitted acquisitions as set forth in the Fifth Amendment.

Item 6: EXHIBITS

The exhibits filed herewith or incorporated by reference herein are listed in the Exhibit Index attached hereto.

EXHIBITS INDEX



Exhibits
3.1		Amendment No.6 dated February 21, 2018 to the Credit Agreement dated as of August 5, 2014, entered into by and among Ebix, Inc., as Borrower, certain subsidiaries of the Company from time to time party thereto, as Guarantors, Regions Bank, as Administrative Agent and Collateral Agent, and the lenders from time to time party thereto. (filed as Exhibit 10.15 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2017 and incorporated herein by reference).
31.1*		Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) (Section 302 of the Sarbanes-Oxley Act of 2002).
31.2*		Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) (Section 302 of the Sarbanes-Oxley Act of 2002).
32.1*		Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*		Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101*		XBRL (Extensible Business Reporting Language) - The following materials from Ebix, Inc.'s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statement of Stockholders' Equity and Comprehensive Income, (iv) the Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements which were tagged as blocks of text.



* Filed herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.




		Ebix, Inc.
Date:	May 10, ~~2017~~2018	By:	/s/ Robin Raina
			Robin Raina
			Chief Executive Officer (Principal Executive Officer)

Date:	May 10, ~~2017~~2018	By:	/s/ Sean T. Donaghy
			Sean T. Donaghy
			Chief Financial Officer (Principal Financial and Accounting Officer)

~~EXHIBIT INDEX~~



~~Exhibits~~
~~3.1~~		Certificate of Incorporation, as amended, of Ebix, Inc. (filed as Exhibit 3.1 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and incorporated herein by reference).
~~3.2~~		Amended and Restated Bylaws of Ebix, Inc., effective immediately following the Company’s Annual Meeting of Stockholders, held on January 9, 2015 (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K dated December 24, 2014).
~~31.1~~*		~~Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) (Section 302 of the Sarbanes-Oxley Act of 2002).~~
~~31.2~~*		~~Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) (Section 302 of the Sarbanes-Oxley Act of 2002).~~
~~32.1~~*		~~Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.~~
~~32.2~~*		~~Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.~~
101*		~~XBRL (Extensible Business Reporting Language) - The following materials from Ebix, Inc.'s Quarterly Report on Form 10-Q for the quarter~~ ~~ended March 31, 2017~~, formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statement of Stockholders' Equity and Comprehensive Income, (iv) the Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements which were tagged as blocks of text.



* Filed herewith

(inIn thousands)

Fair Value at March 31, ~~2017~~2018

Valuation Technique

Significant Unobservable
Input

Contingent acquisition consideration:
(~~Qatarlyst~~Wdev and ~~Wdev~~ItzCash acquisition)

$~~8,753~~36,511

Discounted cash flow

Projected revenue and probability of achievement